FedInvent™ Patents

Patent Details for Tuesday, August 13, 2024 

This page was updated on Tuesday, August 13, 2024 at 05:27 AM GMT

Department of Health and Human Services (HHS) 

US 12058996 Toner et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Breast Cancer Research Program (USAMRMCBCRP)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) The General Hospital Corporation (Boston, Massachusetts)
ASSIGNEE(S) The General Hospital Corporation (Boston, Massachusetts)
INVENTOR(S) Mehmet Toner (Charlestown, Massachusetts);  Mustafa Korkut Uygun (Newton, Massachusetts);  Shannon N. Tessier (Framingham, Massachusetts);  Shannon L. Stott (Stoneham, Massachusetts);  Lindong Weng (Arlington, Massachusetts);  Reinier Johan De Vries (Boston, Massachusetts);  Casie A. Pendexter (Rockland, Massachusetts);  Stephanie E J Cronin (Boston, Massachusetts)
ABSTRACT This disclosure is related to methods of preserving biological samples, organs, and organisms. This disclosure is based, at least in part, on the discovery that in the presence of heterogenous extracellular ice, endothelial cells have improved attachment and viability after preservation, and particularly by uniformly nucleating ice across the microvasculature using ice nucleating agents, the chance of intracelluar ice formation can be significantly reduced.
FILED Thursday, June 14, 2018
APPL NO 16/622457
ART UNIT 1638 — SELECT * FROM codes_techcenter;
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 1/0221 (20130101) Original (OR) Class
A01N 1/0294 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059254 Kintz et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) Profusa, Inc. (Emeryville, California)
ASSIGNEE(S) Profusa, Inc. (Emeryville, California)
INVENTOR(S) Gregory J. Kintz (Santa Cruz, California);  William McMillan (La Honda, California);  Natalie Wisniewski (San Francisco, California)
ABSTRACT An optical device is used to monitor an implant embedded in the tissue of a mammal (e.g., under the skin). The implant receives excitation light from the optical device and emits light that is detected by the optical device, including an analyte-dependent optical signal. Scatter and absorption properties of tissue change over time due to changes in hydration, blood perfusion and oxygenation. The optical device has an arrangement of light sources, filters and detectors to transmit excitation light within excitation wavelength ranges and to measure emitted light within detection wavelengths. Changes in scattering and absorption of light in the tissue, such as diffuse reflectance, are monitored. The light sources, filters and detectors may also be used to monitor autofluorescence in the tissue to correct autofluorescence background.
FILED Monday, October 04, 2021
APPL NO 17/493451
ART UNIT 3798 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/1459 (20130101) Original (OR) Class
A61B 5/7203 (20130101)
A61B 5/14532 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059403 Sah
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) UNIVERSITY OF IOWA RESEARCH FOUNDATION (Iowa City, Iowa)
ASSIGNEE(S) UNIVERSITY OF IOWA RESEARCH FOUNDATION (Iowa City, Iowa)
INVENTOR(S) Rajan Sah (Iowa City, Iowa)
ABSTRACT The invention provides the use of SWELL1 inhibitors and modulators for therapeutic use, e.g., to treat obesity and type 2 diabetes.
FILED Friday, August 04, 2017
APPL NO 16/322709
ART UNIT 1627 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/40 (20130101) Original (OR) Class
A61K 31/138 (20130101)
A61K 31/192 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059407 Murthy et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) The Regents of the University of California (Oakland, California);  Niren Murthy (Berkeley, California);  Joachim Justad Roeise (Berkeley, California);  Chung Hak Taing (Berkeley, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Niren Murthy (Berkeley, California);  Joachim Justad Roeise (Berkeley, California);  Chung Hak Taing (Berkeley, California)
ABSTRACT The present disclosure provides endosomal disruptors, which are useful for facilitating delivery of a macromolecule to the cytoplasm of a cell. The present disclosure provides compositions comprising an endosomal disruptor and a macromolecule. The present disclosure provides methods of delivering a macromolecule to the cytoplasm of a cell.
FILED Monday, December 03, 2018
APPL NO 16/766226
ART UNIT 1624 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/192 (20130101)
A61K 31/4192 (20130101) Original (OR) Class
A61K 38/465 (20130101)
A61K 47/61 (20170801)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059413 Carter et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The Research Foundation for the State University of New York (Albany, New York);  THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland)
ASSIGNEE(S) THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (Albany, New York);  THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (Bethesda, Maryland)
INVENTOR(S) Carol Carter (Huntington, New York);  Lorna Erlich (Shoreham, New York);  Nico Tjandra (Bethesda, Maryland);  Madeleine Davison (Washington, District of Columbia)
ABSTRACT The present invention provides a method of inhibiting release of a virus from a cell, comprising contacting the cell with a compound that binds an ubiquitin E2 variant (UEV) domain of a cellular polypeptide, or fragment thereof, with an affinity sufficient to inhibit or disrupt the binding of the cellular polypeptide, or fragment thereof, to ubiquitin.
FILED Monday, October 30, 2017
APPL NO 16/342695
ART UNIT 1621 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/4439 (20130101) Original (OR) Class

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/56988 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059418 Desai
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland)
INVENTOR(S) Sanjay A. Desai (Potomac, Maryland)
ABSTRACT The invention provides methods of treating or preventing malaria comprising administering to an animal an effective amount of a compound of formula I:
Q-Y—R1—R2  (I),
wherein Q, Y, R1, and R2 are as described herein. Methods of inhibiting a plasmodial surface anion channel of a parasite in an animal are also provided. The invention also provides pharmaceutical compositions comprising a compound represented by formula I in combination with any one or more compounds represented by formulas II, V, and VI. Use of the pharmaceutical compositions for treating or preventing malaria or for inhibiting a plasmodial surface anion channel in animals including humans are also provided. Also provided by the invention are clag3 amino acid sequences and related nucleic acids, vectors, host cells, populations of cells, antibodies, and pharmaceutical compositions.
FILED Tuesday, December 08, 2020
APPL NO 17/115317
ART UNIT 1621 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/42 (20130101)
A61K 31/50 (20130101)
A61K 31/422 (20130101)
A61K 31/423 (20130101)
A61K 31/427 (20130101)
A61K 31/433 (20130101)
A61K 31/433 (20130101)
A61K 31/437 (20130101)
A61K 31/495 (20130101)
A61K 31/496 (20130101)
A61K 31/498 (20130101)
A61K 31/501 (20130101) Original (OR) Class
A61K 31/517 (20130101)
A61K 31/519 (20130101)
A61K 31/554 (20130101)
A61K 31/554 (20130101)
A61K 31/4355 (20130101)
A61K 31/4439 (20130101)
A61K 31/4741 (20130101)
A61K 39/015 (20130101)
A61K 45/06 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)

Heterocyclic Compounds
C07D 239/84 (20130101)
C07D 241/44 (20130101)
C07D 263/57 (20130101)
C07D 277/54 (20130101)
C07D 281/16 (20130101)
C07D 409/04 (20130101)
C07D 409/14 (20130101)
C07D 413/14 (20130101)
C07D 417/06 (20130101)
C07D 491/048 (20130101)
C07D 498/04 (20130101)
C07D 513/04 (20130101)

Peptides
C07K 14/445 (20130101)
C07K 16/205 (20130101)
C07K 2319/21 (20130101)
C07K 2319/43 (20130101)

Technologies for Adaptation to Climate Change
Y02A 50/30 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059426 Marcantonio et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) ARMGO Pharma, Inc. (Ardsley, New York)
ASSIGNEE(S) ARMGO Pharma, Inc. (Ardsley, New York)
INVENTOR(S) Eugene E. Marcantonio (Tenafly, New Jersey);  Mette Uhre Anby (Frederiksberg, Denmark);  Jérôme Binet (Saint Denis en Val, France)
ABSTRACT The present disclosure provides a modified-release pharmaceutical composition comprising 4-[(7-methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)yl)methyl]benzoic acid hemifumarate, and a pharmaceutically-acceptable excipient. The present disclosure methods of treating conditions associated with RyRs, including, for example, cardiac disorder or disease, a musculoskeletal disorder or disease, cancer associated muscle weakness, malignant hyperthermia, and diabetes.
FILED Thursday, July 13, 2023
APPL NO 18/221784
ART UNIT 1617 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/2866 (20130101)
A61K 9/2886 (20130101)
A61K 31/554 (20130101) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 21/00 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059429 Kelly
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) University of Virginia Patent Foundation (Charlottesville, Virginia)
ASSIGNEE(S) University of Virginia Patent Foundation (Charlottesville, Virginia)
INVENTOR(S) Kimberly A. Kelly (Crozet, Virginia)
ABSTRACT Provided are compositions and methods for use of hornerin-binding molecules, including peptides and antibodies. In some embodiments, the presently disclosed subject matter provides compositions that include horning-binding molecules, including but not limited to peptides, uses for the disclosed compositions, including in methods for treating tumors, methods for increasing the survival of subject with tumor, methods for suppressing tumor growth in subjects, methods for reducing tumor vascularity in subjects, methods for treating diseases, disorders, and/or conditions associated with undesirable hornerin expression; methods for modulating hornerin biological activities, methods for imaging cells, tissues, and/or organs that expresses hornerin, and methods for delivering active agents to cells, tissues, and/or organ that expresses hornerin.
FILED Monday, September 16, 2019
APPL NO 16/572234
ART UNIT 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/7105 (20130101) Original (OR) Class
A61K 38/00 (20130101)
A61K 45/06 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Peptides
C07K 7/06 (20130101)
C07K 16/30 (20130101)
C07K 16/2863 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059434 Kalinski
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (Pittsburgh, Pennsylvania)
ASSIGNEE(S) UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (Pittsburgh, Pennsylvania)
INVENTOR(S) Pawel Kalinski (East Aurora, New York)
ABSTRACT Provided herein are ST-αDC1 and populations of those cells, methods for making ST-αDC1 and populations of those cells, and methods for using ST-αDC1 and populations of those cells for the treatment of cancer, precancerous conditions and chronic infections.
FILED Wednesday, February 28, 2018
APPL NO 16/488702
ART UNIT 1644 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/15 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0639 (20130101)
C12N 2501/24 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059435 Morrison
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) THE JOHNS HOPKINS UNIVERSITY (Baltmore, Maryland)
ASSIGNEE(S) The Johns Hopkins University (Baltimore, Maryland)
INVENTOR(S) Brett Morrison (Baltimore, Maryland)
ABSTRACT Provided herein are methods and compositions for increasing nerve regeneration activity of a macrophage, and for inducing and accelerating nerve regeneration of an injured or damaged nerve. Methods and compositions provided herein include upregulating the expression of an MCT1 gene in a macrophage.
FILED Wednesday, August 25, 2021
APPL NO 17/412127
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/15 (20130101) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 25/00 (20180101)

Peptides
C07K 14/47 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059454 Daniell et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, Pennsylvania);  UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (Gainesville, Florida)
ASSIGNEE(S) THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, Pennsylvania);  UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (Gainesville, Florida)
INVENTOR(S) Henry Daniell (Media, Pennsylvania);  Qiuhong Li (Gainesville, Florida);  Mohan K. Raizada (Alachua, Florida)
ABSTRACT Emerging evidence indicates that diminished activity of the vasoprotective axis of the renin-angiotensin system, constituting angiotensin converting enzyme2 (ACE2) and its enzymatic product, angiotensin-(1-7) [Ang-(1-7)] contribute to pulmonary hypertension (PH). However, clinical success for long-term delivery of ACE2 or Ang-(1-7) would require stability and ease of administration to increase patient compliance. Chloroplast expression of therapeutic proteins enables their bioencapsulation within plant cells to protect from acids and gastric enzymes; fusion to a transmucosal carrier facilitates effective systemic absorption. Oral feeding of rats with bioencapsulated ACE2 or Ang-(1-7) attenuated monocrotaline (MCT)-induced increase in right ventricular systolic pressure, decreased pulmonary vessel wall thickness and improved right heart function in both prevention and reversal protocols. Furthermore, combination of ACE2 and Ang-(1-7) augmented the beneficial effects against cardio-pulmonary pathophysiology induced by MCT administration. Experiments have also been performed which indicate that this approach is also suitable for the treatment or inhibition of experimental uveitis and autoimmune uveoretinitis These studies provide proof-of-concept for a novel low-cost oral ACE2 or Ang-(1-7) delivery system using transplastomic technology for pulmonary and ocular disease therapeutics.
FILED Wednesday, February 02, 2022
APPL NO 17/591151
ART UNIT 1654 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/19 (20130101)
A61K 9/0053 (20130101)
A61K 9/1664 (20130101)
A61K 9/5063 (20130101)
A61K 36/23 (20130101)
A61K 36/28 (20130101)
A61K 36/31 (20130101)
A61K 38/22 (20130101)
A61K 38/164 (20130101)
A61K 38/4813 (20130101) Original (OR) Class
A61K 47/65 (20170801)
A61K 47/6415 (20170801)

Peptides
C07K 14/28 (20130101)
C07K 2319/55 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/485 (20130101)
C12N 15/8214 (20130101)
C12N 15/8257 (20130101)

Enzymes
C12Y 304/15001 (20130101)
C12Y 304/17023 (20130101)

Technologies for Adaptation to Climate Change
Y02A 50/30 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059476 Green et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) The Johns Hopkins University (Baltimore, Maryland)
ASSIGNEE(S) THE JOHNS HOPKINS UNIVERSITY (Baltimore, Maryland)
INVENTOR(S) Jordan J. Green (Baltimore, Maryland);  Jonathan Schneck (Blatimore, Maryland);  Alyssa K. Galaro (Baltimore, Maryland);  Randall A. Meyer (Baltimore, Maryland);  John W. Hickey (Baltimore, Maryland);  Kelly Rhodes (Baltimore, Maryland)
ABSTRACT The present invention provides biodegradable, biomimetic particles for interacting with cells, including immune cells. In various embodiments, the particles comprise a polymer blend comprising a polyester, such as poly(lactic-co-glycolic acid) (PLGA) and a polyamine, such as poly(beta-amino ester) (PBAE). The particles further comprise, on their surface, one or more ligands for one or more cell surface receptor(s) or cell surface molecule(s). In some embodiments, the cell surface receptor or cell surface molecule is on an immune cell, such as a lymphocyte (T cell or B cell), natural killer cell, dendritic cell, or other cell of the immune system or tumor microenvironment.
FILED Wednesday, October 10, 2018
APPL NO 16/754951
ART UNIT 1612 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 47/62 (20170801)
A61K 47/6849 (20170801)
A61K 47/6927 (20170801) Original (OR) Class

Peptides
C07K 16/2818 (20130101)
C07K 16/2827 (20130101)
C07K 16/2878 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059480 Ganesh et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Development Command (USAMRDC)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Breast Cancer Research Program (USAMRMCBCRP)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, New York)
ASSIGNEE(S) MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, New York)
INVENTOR(S) Karuna Ganesh (New York, New York);  Manuel Valiente (Madrid, Spain);  Joan Massague (New York, New York)
ABSTRACT The present invention relates to methods and compositions for inhibiting metastatic spread of cancer and/or inhibiting progression of pre-existing metastatic disease in a subject using L1CAM inhibition.
FILED Monday, October 10, 2022
APPL NO 18/045357
ART UNIT 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/337 (20130101)
A61K 31/519 (20130101)
A61K 45/06 (20130101)
A61K 48/0016 (20130101)
A61K 48/0066 (20130101) Original (OR) Class
A61K 48/0083 (20130101)
A61K 48/0091 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/04 (20180101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101)
C12N 2310/11 (20130101)
C12N 2310/14 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/025 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5011 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059482 Bogyo et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, California)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
INVENTOR(S) Matthew S. Bogyo (Redwood City, California);  Martijn Verdoes (Nijmegen, Netherlands)
ABSTRACT Activity-based probe compounds for use in labeling a cysteine protease are provided. The compounds are targeted to the protease through a specific targeting element. The compounds additionally include a detectable element, such as a fluorescent label, a radiolabel, or a chelator. In some cases, the compounds additionally include a quenching element that is released upon reaction with the protease. Also provided are compositions comprising the compounds and methods for using the compounds, for example in labeling a protease in an animal and in visualizing a tumor in an animal.
FILED Friday, December 18, 2020
APPL NO 17/127754
ART UNIT 1618 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 49/0032 (20130101)
A61K 49/0034 (20130101)
A61K 49/0052 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059499 Heath et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) PLUMB PHARMACEUTICALS, INC. (Madison, Wisconsin)
ASSIGNEE(S) PLUMB PHARMACEUTICALS, INC. (Madison, Wisconsin)
INVENTOR(S) Timothy D. Heath (Madison, Wisconsin);  Lisa Ann Krugner-Higby (Belleville, Wisconsin);  Amy Lautenbach (Cottage Grove, Wisconsin)
ABSTRACT Provided herein is technology relating to incorporation of drugs into liposomes and particularly, but not exclusively, to methods for incorporating drugs into liposomes using a weak base and related compositions.
FILED Thursday, May 06, 2021
APPL NO 17/313334
ART UNIT 1612 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/127 (20130101)
A61K 9/1278 (20130101) Original (OR) Class
A61K 31/65 (20130101)
A61K 31/485 (20130101)
A61K 31/4706 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 977/773 (20130101)
Y10S 977/906 (20130101)
Y10S 977/907 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059500 Yantasee et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Oregon Health and Science University (Portland, Oregon);  PDX Pharmaceuticals, Inc. (Portland, Oregon)
ASSIGNEE(S) Oregon Health and Science University (Portland, Oregon);  PDX Pharmaceuticals, Inc. (Portland, Oregon)
INVENTOR(S) Wassana Yantasee (Lake Oswego, Oregon);  Moataz Reda (Portland, Oregon);  Worapol Ngamcherdtrakul (Portland, Oregon)
ABSTRACT Disclosed herein are therapeutic constructs including a delivery particle, at least one mitotic kinase inhibitor, and at least one immune checkpoint inhibitor. Also disclosed are therapeutic constructs including a mitotic kinase inhibitor, an immune checkpoint inhibitor, and a chemical linker. These therapeutic constructs cause cancer death by both therapeutic and immune effects and promote targeted delivery of more therapeutics to the surviving cancer cells in a positive feed-back loop. They enhance therapeutic index of free drugs and can be used intratumorally or systemically. This strategy can treat broad cancer types and is particular useful for cancer without obvious receptors for cancer-targeted delivery of otherwise toxic therapeutics.
FILED Wednesday, May 10, 2023
APPL NO 18/315448
ART UNIT 1611 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 9/143 (20130101) Original (OR) Class
A61K 9/146 (20130101)
A61K 31/519 (20130101)
A61K 45/06 (20130101)
A61K 47/6803 (20170801)
A61K 47/6849 (20170801)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 5/00 (20130101)

Peptides
C07K 16/2827 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059582 Kiani
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) The Penn State Research Foundation (University Park, Pennsylvania)
ASSIGNEE(S) The Penn State Research Foundation (University Park, Pennsylvania)
INVENTOR(S) Mehdi Kiani (State College, Pennsylvania)
ABSTRACT A method and system of neural stimulation and imaging of nervous system of a subject. The method includes the steps of providing an interface device operable to generate an ultrasonic beam for neuroniodulation and imaging of a targeted neural structure of a subject, implanting the interface device in the subject, and providing and disposing an external coil array over the targeted neural structure of the subject, wherein the external coil array is wirelessly powering and communicating with the interface device.
FILED Friday, October 11, 2019
APPL NO 17/283983
ART UNIT 3798 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 8/42 (20130101)
A61B 8/565 (20130101)
A61B 8/0808 (20130101)
A61B 8/4472 (20130101)
A61B 8/4483 (20130101)
A61B 8/4488 (20130101)
A61B 8/4494 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/0534 (20130101)
A61N 1/37223 (20130101)
A61N 1/37235 (20130101)
A61N 7/00 (20130101) Original (OR) Class
A61N 2007/0026 (20130101)
A61N 2007/0047 (20130101)
A61N 2007/0052 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060318 Lu et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Science Foundation (NSF)
Directorate for STEM Education (EDU)
Directorate for Education and Human Resources (EHR)
Division of Graduate Education (DGE)
APPLICANT(S) CASE WESTERN RESERVE UNIVERSITY (Cleveland, Ohio)
ASSIGNEE(S) CASE WESTERN RESERVE UNIVERSITY (Cleveland, Ohio)
INVENTOR(S) Zheng-Rong Lu (Cleveland, Ohio);  Da Sun (Cleveland, Ohio);  Rebecca Schur (Cleveland, Ohio)
ABSTRACT A nanosized complex includes a nucleic acid and a compound comprising formula (I): wherein R1 is an alkylamino group or a group containing at least one aromatic group; R2 and R3 are independently an aliphatic group or hydrophobic group; R4 and R5 are independently H, a substituted or unsubstituted alkyl group, an alkenyl group, an acyl group, or an aromatic group, or a polymer, a targeting group, a detectable moiety, or a linker, or a combination thereof, and at least one of R4 and R5 includes a retinoid or retinoid derivative that targets and/or binds to an interphotoreceptor retinoid binding protein; a, b, c, and d are independently an integer from 1 to 10; and pharmaceutically acceptable salts thereof.
FILED Thursday, July 30, 2020
APPL NO 16/943008
ART UNIT 1699 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/51 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 5/00 (20130101)

Acyclic or Carbocyclic Compounds
C07C 403/10 (20130101) Original (OR) Class
C07C 403/12 (20130101)
C07C 403/14 (20130101)
C07C 403/20 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060330 Freundlich et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (New Brunswick, New Jersey)
ASSIGNEE(S) RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (New Brunswick, New Jersey)
INVENTOR(S) Joel S. Freundlich (New Brunswick, New Jersey);  David Alland (New Brunswick, New Jersey);  Matthew B. Neiditch (New Brunswick, New Jersey);  Pradeep Kumar (New Brunswick, New Jersey);  Glenn Capodagli (New Brunswick, New Jersey);  Divya Awasthi (New Brunswick, New Jersey);  Sean Ekins (New Brunswick, New Jersey)
ABSTRACT The invention provides compounds of formula I:
and salts thereof wherein R1-R5 have any of the meanings described in the specification. The compounds are useful for treating bacterial infections (e.g. tuberculosis).
FILED Tuesday, November 02, 2021
APPL NO 17/517569
ART UNIT 1629 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/4409 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/06 (20180101)

Heterocyclic Compounds
C07D 231/56 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060332 Betts et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Tampa, Florida)
ASSIGNEE(S) H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Tampa, Florida)
INVENTOR(S) Brian Betts (Tampa, Florida);  Said M. Sebti (Tampa, Florida);  Harshani Lawrence (Tampa, Florida);  Nicholas Lawrence (Tampa, Florida);  Claudio Anasetti (Tampa, Florida);  Joseph Pidala (Tampa, Florida)
ABSTRACT Disclosed herein are compounds and methods for reducing the risk of developing, preventing, or treating graft versus host disease (GVHD) in a subject. The compounds can concurrently block Aurora kinase A and JAK2 signal transduction which synergistically suppresses alloreactive human T-cells in vitro, prevents xenogeneic graft-versus-host disease without impairing anti-tumor responses, and promotes the development and suppressive potency of CD39+ inducible Treg. In certain aspects, disclosed are compounds of Formula I-V.
FILED Thursday, January 19, 2023
APPL NO 18/098990
ART UNIT 1624 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/505 (20130101)
A61K 31/506 (20130101)
A61K 45/06 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Heterocyclic Compounds
C07D 239/48 (20130101) Original (OR) Class
C07D 401/12 (20130101)
C07D 403/12 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060334 Huigens, III et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) University of Florida Research Foundation, Incorporated (Gainesville, Florida)
ASSIGNEE(S) University of Florida Research Foundation, Incorporated (Gainesville, Florida)
INVENTOR(S) Robert William Huigens, III (Williston, Florida);  Hongfen Yang (Gainesville, Florida)
ABSTRACT The present invention provides phenazine derivatives, such as compounds of Formula (I). The compounds of the invention are expected to be antimicrobial agents and may act by a microbial warfare strategy (e.g., a reactive oxygen species (ROS)-based competition strategy). The present invention also provides compositions, kits, uses, and methods that involve the compounds of the invention, which may be useful in preventing or treating a microbial infection (e.g., a bacterial infection or mycobacterial infection) in a subject, inhibiting the growth and/or reproduction of a microorganism (e.g., a bacterium or mycobacterium), killing a microorganism (e.g., a bacterium or mycobacterium), inhibiting the formation and/or growth of a biofilm, reducing or clearing a biofilm, and/or disinfecting a surface.
FILED Friday, March 11, 2022
APPL NO 17/692536
ART UNIT 1624 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 241/46 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060337 Tepe et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Board of Trustees of Michigan State University (East Lansing, Michigan)
ASSIGNEE(S) Board of Trustees of Michigan State University (East Lansing, Michigan)
INVENTOR(S) Jetze J. Tepe (East Lansing, Michigan);  Theresa A. Lansdell (East Lansing, Michigan);  Evert Njomen (Ypsilanti, Michigan);  Corey Lee Jones (Madison, Wisconsin)
ABSTRACT The disclosure is directed to substituted dibenzo[b,f]azepines of the formula (II): wherein the variables n, X3, R1, R2, R4, and R5 are defined herein, and uses of such compounds to treat conditions including neurodegenerative diseases and cancers.
FILED Monday, February 14, 2022
APPL NO 17/671480
ART UNIT 1624 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 279/22 (20130101) Original (OR) Class
C07D 417/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060350 David et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) REGENTS OF THE UNIVERSITY OF MINNESOTA (Minneapolis, Minnesota)
ASSIGNEE(S) REGENTS OF THE UNIVERSITY OF MINNESOTA (Minneapolis, Minnesota)
INVENTOR(S) Sunil A. David (Minneapolis, Minnesota);  Yupeng Li (Minneapolis, Minnesota);  Michael Brush (Minneapolis, Minnesota);  Kathryn Trautman (Minneapolis, Minnesota);  Collin Gustafson (Minneapolis, Minnesota);  Daniel Maurer (Minneapolis, Minnesota);  Balaji Pathakumari (Minneapolis, Minnesota)
ABSTRACT The invention provides a compound of formula (I) or a salt thereof, wherein R1, R2, R3 and R4 have any of the values described in the specification, as well as compositions comprising a compound of formula (I). The compounds are useful as immunostimulatory agents.
custom character
FILED Friday, June 28, 2019
APPL NO 17/256933
ART UNIT 1621 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/39 (20130101)
A61K 47/61 (20170801)
A61K 47/545 (20170801)
A61K 47/6923 (20170801)
A61K 2039/55511 (20130101)

Heterocyclic Compounds
C07D 471/04 (20130101) Original (OR) Class

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 9/6561 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060358 Ibrahim et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) University of Mississippi (University, Mississippi)
ASSIGNEE(S)
INVENTOR(S) Mohamed Ali Mohamed Ali Ibrahim (Oxford, Mississippi);  Jason Richard Paris (Little Rock, Arkansas);  Larry Anthony Walker (Milan, Tennessee);  Abbas Gholipour Shilabin (Johnson City, Tennessee);  Meirambek Ospanov (Oxford, Mississippi)
ABSTRACT The disclosure relates to compounds of Formula I, methods of making same, pharmaceutical compositions including same, and methods of treating pain and neurological disorders using same: wherein R1 is hydrogen, halogen, hydroxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, aryl, nitro, or cyano; wherein R2 and R3 are independently hydrogen, halogen, aryl, or substituted or unsubstituted alkyl, or wherein R2 and R3 are connected to form an alkyl chain; wherein R4 is a substituted or unsubstituted aryl or heteroaryl group having from 5 to 10 members; wherein X is O, S, N, NH, CH, CH2, or CO; wherein n is from 0 to 10; and wherein the bond indicated by * is a double bond or a single bond based on a valence of X. The compounds selectively bind to CB2, can penetrate the blood brain barrier, and have a half-life of 20 hours or greater.
FILED Tuesday, March 28, 2023
APPL NO 18/191247
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 25/04 (20180101)

Heterocyclic Compounds
C07D 487/04 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060366 Gray et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) DANA-FARBER CANCER INSTITUTE, INC. (Boston, Massachusetts)
ASSIGNEE(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
INVENTOR(S) Nathanael Gray (Boston, Massachusetts);  Tinghu Zhang (Brookline, Massachusetts);  Eric Fischer (Chestnut Hill, Massachusetts);  Alyssa Verano (Allston, Massachusetts);  Zhixiang He (Brookline, Massachusetts);  Guangyan Du (Jamaica Plain, Massachusetts);  Katherine Donovan (Boston, Massachusetts);  Radoslaw Nowak (Boston, Massachusetts);  Jing Ting Christine Yuan (Brookline, Massachusetts)
ABSTRACT Disclosed are degraders, pharmaceutical compositions containing them, and methods of making and using the degraders to treat diseases and disorders characterized by aberrant protein activity that can be targeted by cereblon.
FILED Thursday, June 27, 2019
APPL NO 17/255772
ART UNIT 1624 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 47/55 (20170801)
A61K 47/545 (20170801)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Heterocyclic Compounds
C07D 495/14 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060388 DiMaio et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) YALE UNIVERSITY (New Haven, Connecticut)
ASSIGNEE(S) YALE UNIVERSITY (New Haven, Connecticut)
INVENTOR(S) Daniel DiMaio (North Haven, Connecticut);  Pengwei Zhang (New Haven, Connecticut);  Gabriel Monteiro Da Silva (Ribeirao Preto, Brazil);  Weiya Bai (Shanghai, China PRC)
ABSTRACT In various aspects and embodiments the invention provides compositions and methods for facilitating cell penetration of a cargo molecule. In another aspect, the invention provides a method of preventing viral infection in a subject in need thereof, the method comprising providing to the subject a therapeutically effective amount of a polypeptide comprising a cell-penetrating peptide and a retromer binding site.
FILED Friday, May 24, 2019
APPL NO 17/057501
ART UNIT 1658 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0014 (20130101)
A61K 38/00 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/20 (20180101)

Peptides
C07K 14/005 (20130101) Original (OR) Class
C07K 2319/33 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 2710/20022 (20130101)
C12N 2710/20033 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060393 Kalyanasundaram
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) The Board of Trustees of the University of Illinois (Urbana, Illinois)
ASSIGNEE(S) THE BD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (Urbana, Illinois)
INVENTOR(S) Ramaswamy Kalyanasundaram (Rockford, Illinois)
ABSTRACT The present invention is a multivalent vaccine for immunizing an animal against filariasis. In some embodiments, the antigens of the multivalent vaccine are protein-based, DNA-based, or a combination thereof. This invention also provides a method and kit for detecting a filarial nematode and determining vaccine efficacy.
FILED Wednesday, August 29, 2018
APPL NO 16/116203
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/0003 (20130101)
A61K 2039/53 (20130101)
A61K 2039/70 (20130101)
A61K 2039/545 (20130101)
A61K 2039/55505 (20130101)

Peptides
C07K 14/4354 (20130101) Original (OR) Class
C07K 2319/00 (20130101)
C07K 2319/40 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/0065 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/56966 (20130101)
G01N 2333/4353 (20130101)
G01N 2469/10 (20130101)
G01N 2469/20 (20130101)

Technologies for Adaptation to Climate Change
Y02A 50/30 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060394 Sentman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) THE TRUSTEES OF DARTMOUTH COLLEGE (Hanover, New Hampshire)
ASSIGNEE(S) THE TRUSTEES OF DARTMOUTH COLLEGE (Hanover, New Hampshire)
INVENTOR(S) Charles L. Sentman (Grantham, New Hampshire);  Albert Gacerez (Lebanon, New Hampshire)
ABSTRACT Nucleic acid constructs, vectors, and recombinant cells harboring the nucleic acid constructs or vectors are disclosed. The nucleic acid constructs include genes encoding a chimeric antigen receptor (CAR) and/or one or more transcription factors, optionally mutated. The transcription factors include those that mediate proinflammatory cytokine expression, e.g., T-bet, STAT1, or STAT4. Methods are disclosed of co-expression of the CAR and the transcription factor in a human or non-human immune cell, preferably human T cells. Also disclosed are methods for using these cells for immunotherapy, e.g., in treating cancer, infection, autoimmunity, allergy or inflammation diseases by the administration of a prophylactically or therapeutically effective amount of one or more of the nucleic acid constructs, vectors, and/or immune cells, e.g., human CAR-T cells, described herein.
FILED Friday, April 28, 2017
APPL NO 16/096562
ART UNIT 1631 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/17 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Peptides
C07K 14/4702 (20130101) Original (OR) Class
C07K 14/7051 (20130101)
C07K 14/70521 (20130101)
C07K 16/2827 (20130101)
C07K 2317/622 (20130101)
C07K 2319/03 (20130101)
C07K 2319/33 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/86 (20130101)
C12N 2740/10043 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060395 Ildefonso et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) University of Florida Research Foundation, Incorporated (Gainesville, Florida)
ASSIGNEE(S) University of Florida Research Foundation, Incorporated (Gainesville, Florida)
INVENTOR(S) Cristhian J. Ildefonso (Gainesville, Florida);  Alfred S. Lewin (Gainesville, Florida);  Qiuhong Li (Gainesville, Florida)
ABSTRACT The present invention provides methods and compositions for treating and/or preventing age related macular degeneration and other conditions involving macular degeneration, ocular neovascularization, or inflammation, including ocular inflammation. In some embodiments, the methods comprise administering an expression vector that delivers a secretable and cell penetrating Nrf2 to a subject in need thereof.
FILED Tuesday, June 08, 2021
APPL NO 17/342120
ART UNIT 1658 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0048 (20130101)
A61K 38/1709 (20130101)
A61K 48/0075 (20130101)

Peptides
C07K 14/4702 (20130101) Original (OR) Class
C07K 2319/00 (20130101)
C07K 2319/02 (20130101)
C07K 2319/10 (20130101)
C07K 2319/50 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060396 Pozzi et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) Vanderbilt University (Nashville, Tennessee);  The United States as Represented by The Department of Veterans Affairs (Washington, District of Columbia)
ASSIGNEE(S) Vanderbilt University (Nashville, Tennessee);  The United States as Represented by the Department of Veterans Affairs (Washington, District of Columbia)
INVENTOR(S) Ambra A. Pozzi (Nashville, Tennessee);  Manuel Chiusa (Nashville, Tennessee);  Jack J. Hawiger (Nashville, Tennessee);  Jozef Zienkiewicz (Nashville, Tennessee)
ABSTRACT Disclosed herein are compositions and methods for inhibiting collagen production mediated by the Fused in Sarcoma (FUS) ribonucleoprotein. As disclosed herein, the C terminal domain of FUS contains an uncommon nuclear localization sequence (NLS) motif called PY-NLS that binds the nuclear import receptor transportin. Phosphorylation of FUS leads to its association with transportin and nuclear translocation with consequent increased in collagen production. Therefore, disclosed herein is an isolated peptide having a transportin-binding moiety, which inhibits FUS from binding transportin, linked to a membrane translocating motif. These compositions and methods can be used to inhibit FUS-mediated collagen production, and treat fibrotic disease involving FUS-mediated collagen accumulation in kidneys and other organs displaying fibrotic diseases.
FILED Monday, January 29, 2018
APPL NO 16/481128
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/1709 (20130101)
A61K 38/1777 (20130101)
A61K 38/1825 (20130101)
A61K 45/06 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 13/12 (20180101)

Peptides
C07K 14/50 (20130101)
C07K 14/4703 (20130101) Original (OR) Class
C07K 14/70557 (20130101)
C07K 2319/02 (20130101)
C07K 2319/10 (20130101)
C07K 2319/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060397 Cohen et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Tufts Medical Center (Boston, Massachusetts);  Trustees of Tufts College (Medford, Massachusetts);  On Target Therapeutics LLC (Wellesley, Massachusetts)
ASSIGNEE(S) Tufts Medical Center (Boston, Massachusetts);  Trustees of Tufts College (Medford, Massachusetts);  On Target Therapeutics LLC (Wellesley, Massachusetts)
INVENTOR(S) Charles Cohen (Weston, Massachusetts);  Krishna Kumar (Cambridge, Massachusetts);  Jamie Raudensky Doyle (Newton, Massachusetts);  Alan S. Kopin (Wellesley, Massachusetts)
ABSTRACT The present application provides methods for preparing soluble lipidated ligand agents comprising a ligand entity and a lipid entity, and in some embodiments, provides relevant parameters of each of these components, thereby enabling appropriate selection of components to assemble active agents for any given target of interest.
FILED Friday, November 12, 2021
APPL NO 17/525169
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)
A61K 47/543 (20170801)

Peptides
C07K 7/06 (20130101)
C07K 7/08 (20130101)
C07K 14/4703 (20130101) Original (OR) Class

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/92 (20130101)
G01N 33/5023 (20130101)
G01N 2405/00 (20130101)
G01N 2440/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060411 Nussenzweig et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) The Rockefeller University (New York, New York)
ASSIGNEE(S) The Rockefeller University (New York, New York)
INVENTOR(S) Michel Nussenzweig (New York, New York);  Zijun Wang (New York, New York)
ABSTRACT This disclosure provides novel neutralizing anti-SARS-CoV-2 antibodies or antigen-binding fragments thereof. The disclosed anti-SARS-CoV-2 antibodies constitute a novel therapeutic strategy in protection from SARS-CoV-2 infections.
FILED Thursday, January 13, 2022
APPL NO 17/575246
ART UNIT 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/42 (20130101)
A61K 45/06 (20130101)

Peptides
C07K 16/10 (20130101) Original (OR) Class
C07K 2317/31 (20130101)
C07K 2317/35 (20130101)
C07K 2317/76 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/56983 (20130101)
G01N 2333/165 (20130101)
G01N 2800/26 (20130101)
G01N 2800/52 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060412 Regev et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) THE BROAD INSTITUTE, INC. (Cambridge, Massachusetts);  MASSACHUSETTS INSTITUTE OF TECHNOLOGY (Cambridge, Massachusetts);  PRESIDENT AND FELLOWS OF HARVARD COLLEGE (Cambridge, Massachusetts)
ASSIGNEE(S) The Broad Institute, Inc. (Cambridge, Massachusetts);  Massachusetts Institute of Technology (Cambridge, Massachusetts);  President and Fellows of Harvard College, MA (Cambridge, Massachusetts)
INVENTOR(S) Aviv Regev (Cambridge, Massachusetts);  Feng Zhang (Cambridge, Massachusetts);  Naomi Habib (Cambridge, Massachusetts);  Yinqing Li (Cambridge, Massachusetts);  Matthias Heidenreich (Cambridge, Massachusetts);  Lukasz Swiech (Cambridge, Massachusetts);  Anindita Basu (Cambridge, Massachusetts);  David Weitz (Cambridge, Massachusetts);  Inbal Avraham Davidi (Cambridge, Massachusetts)
ABSTRACT Transcriptomes of individual neurons provide rich information about cell types and dynamic states. However, it is difficult to capture rare dynamic processes, such as adult neurogenesis, because isolation from dense adult tissue is challenging, and markers for each phase are limited. Here, Applicants developed Nuc-seq, Div-Seq, and Dronc-Seq. Div-seq combines Nuc-Seq, a scalable single nucleus RNA-Seq method, with EdU-mediated labeling of proliferating cells. Nuc-Seq can sensitively identify closely related cell types within the adult hippocampus. Div-Seq can track transcriptional dynamics of newborn neurons in an adult neurogenic region in the hippocampus. Dronc-Seq uses a microfluidic device to co-encapsulate individual nuclei in reverse emulsion aqueous droplets in an oil medium together with one uniquely barcoded mRNA-capture bead. Finally, Applicants found rare adult newborn GABAergic neurons in the spinal cord, a non-canonical neurogenic region. Taken together, Nuc-Seq, Div-Seq and Dronc-Seq allow for unbiased analysis of any complex tissue.
FILED Thursday, October 27, 2016
APPL NO 16/087036
ART UNIT 1675 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Peptides
C07K 16/1036 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1093 (20130101)
C12N 15/1096 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/686 (20130101)
C12Q 1/6869 (20130101)
C12Q 1/6869 (20130101)
C12Q 2537/165 (20130101)
C12Q 2537/165 (20130101)
C12Q 2563/179 (20130101)
C12Q 2563/179 (20130101)
C12Q 2565/514 (20130101)
C12Q 2565/514 (20130101)
C12Q 2565/629 (20130101)
C12Q 2565/629 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060415 Pasqualini et al.
FUNDED BY
Department of Energy (DOE)
Los Alamos National Security, LLC (LANS)
National Nuclear Security Administration (NNSA)
Los Alamos National Laboratory (LANL)
Federally Funded Research and Development Center (FFRDC)
Operated by Triad National Security, LLC (TRIAD) at Los Alamos, NM
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) Rutgers, The State University of New Jersey (New Brunswick, New Jersey)
ASSIGNEE(S) Rutgers, The State University of New Jersey (New Brunswick, New Jersey)
INVENTOR(S) Renata Pasqualini (New Brunswick, New Jersey);  Wadih Arap (New Brunswick, New Jersey);  Fernanda Iamassaki Staquicini (New Brunswick, New Jersey);  Fortunato Ferrara (Santa Fe, New Mexico);  Sara D'Angelo (Santa Fe, New Mexico);  Andrew R. M. Bradbury (Santa Fe, New Mexico)
ABSTRACT Isolated or recombinant EphA5 or GRP78 targeting antibodies are provided. In some cases, antibodies of the embodiments can be used for the detection, diagnosis and/or therapeutic treatment of human diseases, such as cancer. A method of rapidly identifying antibodies or antibody fragments for the treatment of cancer using a combination of in vitro and in vivo methodologies is also provided.
FILED Friday, February 04, 2022
APPL NO 17/592828
ART UNIT 1646 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/07 (20130101)
A61K 39/3955 (20130101)
A61K 39/39558 (20130101)
A61K 47/6803 (20170801)
A61K 47/6817 (20170801)
A61K 47/6843 (20170801)
A61K 47/6849 (20170801)
A61K 47/6891 (20170801)
A61K 49/0008 (20130101)
A61K 2039/505 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Peptides
C07K 14/47 (20130101)
C07K 16/005 (20130101)
C07K 16/18 (20130101) Original (OR) Class
C07K 16/28 (20130101)
C07K 16/30 (20130101)
C07K 16/2866 (20130101)
C07K 16/3023 (20130101)
C07K 2317/21 (20130101)
C07K 2317/35 (20130101)
C07K 2317/55 (20130101)
C07K 2317/73 (20130101)
C07K 2317/77 (20130101)
C07K 2317/622 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/64 (20130101)
C12N 15/1037 (20130101)
C12N 2810/00 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6869 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/574 (20130101)
G01N 33/5011 (20130101)
G01N 33/57423 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060555 Ahangari et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Yale University (New Haven, Connecticut);  University of Connecticut (Farmington, Connecticut)
ASSIGNEE(S) YALE UNIVERSITY (New Haven, Connecticut);  UNIVERSITY OF CONNECTICUT (Farmington, Connecticut)
INVENTOR(S) Farida Ahangari (New Haven, Connecticut);  Naftali Kaminski (New Haven, Connecticut);  Carlos Fernandez-Hernando (New Haven, Connecticut);  Raman Bahal (Glastonbury, Connecticut)
ABSTRACT In one aspect, the present disclosure provides a microRNA-33 (miR-33) inhibitor comprising a peptide nucleic acid covalently bound to a pH low insertion peptide. In another aspect, the present disclosure provides a method of treating pulmonary fibrosis in a subject, the method comprising administering to the subject a therapeutically effective amount of the miR-33 inhibitor. In some embodiments, the pulmonary fibrosis is idiopathic pulmonary fibrosis.
FILED Friday, May 13, 2022
APPL NO 17/663378
ART UNIT 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/713 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 9/10 (20180101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/111 (20130101) Original (OR) Class
C12N 15/113 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060576 Thon et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Stellular Bio, Inc. (Watertown, Massachusetts)
ASSIGNEE(S) Stellular Bio, Inc. (Watertown, Massachusetts)
INVENTOR(S) Jonathan Thon (Watertown, Massachusetts);  Brad Dykstra (Watertown, Massachusetts)
ABSTRACT Methods for producing megakaryocytic progenitors (preMKs) and megakaryocytes (MKs) from stem cells are provided. The present disclosure further provides compositions comprising preMKs and MKs and their lysates, and also methods of use of preMKs, MKs, their lysates and compositions thereof.
FILED Saturday, January 05, 2019
APPL NO 16/957918
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0075 (20130101)
C12N 5/0644 (20130101) Original (OR) Class
C12N 2501/91 (20130101)
C12N 2501/115 (20130101)
C12N 2501/125 (20130101)
C12N 2501/145 (20130101)
C12N 2501/155 (20130101)
C12N 2501/165 (20130101)
C12N 2501/415 (20130101)
C12N 2501/2303 (20130101)
C12N 2501/2306 (20130101)
C12N 2501/2309 (20130101)
C12N 2506/45 (20130101)
C12N 2513/00 (20130101)
C12N 2533/52 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060579 Murry et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) UNIVERSITY OF WASHINGTON (Seattle, Washington)
ASSIGNEE(S) UNIVERSITY OF WASHINGTON (Seattle, Washington)
INVENTOR(S) Charles E. Murry (Seattle, Washington);  Lil Pabon (Seattle, Washington);  Nathan Palpant (Seattle, Washington)
ABSTRACT Provided herein are methods that enable the polarization of hPSC mesoderm such that closely related yet distinct cardiovascular populations can be generated efficiently without the need of post-facto enrichment.
FILED Wednesday, February 26, 2020
APPL NO 16/801559
ART UNIT 1632 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/545 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0657 (20130101) Original (OR) Class
C12N 2501/16 (20130101)
C12N 2501/115 (20130101)
C12N 2501/155 (20130101)
C12N 2501/165 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060588 Jaenisch et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Child Health and Human Development (NICHD)
APPLICANT(S) Whitehead Institute for Biomedical Research (Cambridge, Massachusetts)
ASSIGNEE(S) Whitehead Institute for Biomedical Research (Cambridge, Massachusetts)
INVENTOR(S) Rudolf Jaenisch (Brookline, Massachusetts);  X. Shawn Liu (Cambridge, Massachusetts);  Hao Wu (Newton, Massachusetts)
ABSTRACT The invention relates to methods of modifying DNA methylation by contacting a cell with a catalytically inactive site specific nuclease fused to an effector domain having methylation or demethylation activity and one or more guide sequences.
FILED Wednesday, July 06, 2022
APPL NO 17/858758
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/30 (20130101)
A61K 35/33 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/22 (20130101) Original (OR) Class
C12N 9/1007 (20130101)
C12N 15/11 (20130101)
C12N 15/86 (20130101)
C12N 15/907 (20130101)
C12N 2310/20 (20170501)
C12N 2740/15031 (20130101)
C12N 2800/80 (20130101)

Enzymes
C12Y 201/01037 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060611 Salomon et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) THE SCRIPPS RESEARCH INSTITUTE (La Jolla, California);  NORTHWESTERN UNIVERSITY (Evanston, Illinois)
ASSIGNEE(S) THE SCRIPPS RESEARCH INSTITUTE (La Jolla, California);  NORTHWESTERN UNIVERSITY (Evanston, Illinois)
INVENTOR(S) Daniel Salomon (San Diego, California);  John Friedewald (Chicago, Illinois);  Sunil Kurian (San Diego, California);  Michael M. Abecassis (Highland Park, Illinois);  Steve Head (Lakeside, California);  Phillip Ordoukhanian (San Diego, California)
ABSTRACT By a genome-wide gene analysis of expression profiles of over 50,000 known or putative gene sequences in peripheral blood, the present inventors have identified a consensus set of gene expression-based molecular biomarkers associated with subclinical acute rejection (subAR). These genes sets are useful for diagnosis, prognosis, monitoring of subAR.
FILED Thursday, September 12, 2019
APPL NO 16/569119
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6883 (20130101) Original (OR) Class
C12Q 2537/165 (20130101)
C12Q 2600/106 (20130101)
C12Q 2600/112 (20130101)
C12Q 2600/118 (20130101)
C12Q 2600/158 (20130101)

Bioinformatics, i.e Information and Communication Technology [ICT] Specially Adapted for Genetic or Protein-related Data Processing in Computational Molecular Biology
G16B 20/00 (20190201)
G16B 25/10 (20190201)
G16B 40/20 (20190201)
G16B 40/30 (20190201)

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 20/40 (20180101)
G16H 50/20 (20180101)
G16H 50/30 (20180101)

Technologies for Adaptation to Climate Change
Y02A 90/10 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060615 Nelson et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The Johns Hopkins University (Baltimore, Maryland)
ASSIGNEE(S) The Johns Hopkins University (Baltimore, Maryland)
INVENTOR(S) William G. Nelson (Towson, Maryland);  Srinivasan Yegnasubramanian (Baltimore, Maryland);  Xiaohui Lin (Redlands, California);  Traci J. Speed (Baltimore, Maryland);  Zachery Reichert (Baltimore, Maryland)
ABSTRACT The present invention provides methods for discovering agents that are effective in reversing epigenetic silencing by inhibiting the interaction of methyl-binding (MBD) proteins with methylated genomic DNA. Also provided are methods for reactivating silenced genes having CpG island hypermethylation along with methods for treatment and prevention of diseases, such as cancer and sickle cell anemia, by administering an agent that modulates methyl-binding domain (MBD) protein-mediated transcriptional repression, thereby increasing gene transcription to prevent or treat disease. Additionally, compounds identified by the present invention useful for treatment and prevention of diseases, such as cancer and sickle cell anemia, are provided.
FILED Monday, February 25, 2019
APPL NO 16/285019
ART UNIT 1699 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/136 (20130101)
A61K 31/381 (20130101)
A61K 31/404 (20130101)
A61K 31/433 (20130101)
A61K 31/444 (20130101)
A61K 31/517 (20130101)
A61K 31/519 (20130101)
A61K 31/4184 (20130101)
A61K 31/4188 (20130101)
A61K 31/4245 (20130101)
A61K 31/4439 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101) Original (OR) Class
C12Q 2600/136 (20130101)
C12Q 2600/154 (20130101)
C12Q 2600/158 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5011 (20130101)
G01N 33/6875 (20130101)
G01N 2500/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060618 Barlogie et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) BioVentures, LLC (Little Rock, Arkansas)
ASSIGNEE(S) BioVentures LLC (Little Rock, Arkansas)
INVENTOR(S) Bart Barlogie (Little Rock, Arkansas);  Pingping Qu (Little Rock, Arkansas);  Christoph Heuck (Little Rock, Arkansas);  Joshua Epstein (Little Rock, Arkansas)
ABSTRACT The invention provides, inter alia, methods of prognosing a subject with, or suspected of having, multiple myeloma. In certain embodiments, the methods entail testing the gene expression levels of enolase 1 (ENO1), fatty acid binding protein 5 (FABP5), thyroid hormone receptor interactor 13 (TRIP13), transgelin 2 (TAGLN2), and replication factor C (activator 1) 4 (RFC4) in a biological sample isolated from the subject. The invention also provides methods of treatment for multiple myeloma, as well as kits, oligonucleotides, and systems for performing the methods provided by the invention.
FILED Monday, August 24, 2020
APPL NO 17/001173
ART UNIT 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101) Original (OR) Class
C12Q 2600/16 (20130101)
C12Q 2600/112 (20130101)
C12Q 2600/118 (20130101)
C12Q 2600/158 (20130101)

Bioinformatics, i.e Information and Communication Technology [ICT] Specially Adapted for Genetic or Protein-related Data Processing in Computational Molecular Biology
G16B 25/00 (20190201)
G16B 25/10 (20190201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061143 Dickson et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Georgia Tech Research Corporation (Atlanta, Georgia)
ASSIGNEE(S) Georgia Tech Research Corporation (Atlanta, Georgia)
INVENTOR(S) Robert Martin Dickson (Atlanta, Georgia);  Tzu-Hsueh Huang (Atlanta, Georgia)
ABSTRACT The invention is directed to a method for rapidly determining antibiotic susceptibility in bodily fluid samples based on rigorous multidimensional statistical metrics. In some embodiments, the method incorporates flow cytometry to determine susceptibility. In preferred embodiments, the method is adapted for use with samples with low bacterial counts.
FILED Friday, January 12, 2018
APPL NO 16/477260
ART UNIT 1759 — Electrical Circuits and Systems
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/18 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 15/1459 (20130101) Original (OR) Class
G01N 21/39 (20130101)
G01N 2015/1006 (20130101)
G01N 2015/1402 (20130101)
G01N 2015/1488 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061186 Spranger et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Stefani Spranger (Boston, Massachusetts);  Ellen Duong (Quincy, Massachusetts)
ABSTRACT Provided herein are compositions and methods of use relating to a novel class of dendritic cells, referred to herein as ISG+ DC, having anti-tumor activity.
FILED Tuesday, June 15, 2021
APPL NO 17/348704
ART UNIT 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6869 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 15/14 (20130101)
G01N 33/5047 (20130101) Original (OR) Class
G01N 33/6893 (20130101)
G01N 33/57492 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061187 Birnbaum et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Breast Cancer Research Program (USAMRMCBCRP)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Michael Birnbaum (Cambridge, Massachusetts);  Connor Dobson (Somerville, Massachusetts)
ABSTRACT Compositions of retroviruses and methods of using the same for gene delivery, wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.
FILED Monday, March 23, 2020
APPL NO 16/826665
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Peptides
C07K 14/005 (20130101)
C07K 14/4748 (20130101)
C07K 14/5437 (20130101)
C07K 14/70532 (20130101)
C07K 14/70539 (20130101)
C07K 16/2803 (20130101)
C07K 2317/622 (20130101)
C07K 2319/02 (20130101)
C07K 2319/035 (20130101)
C07K 2319/60 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/86 (20130101)
C12N 2740/15045 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/505 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061188 Birnbaum et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Breast Cancer Research Program (USAMRMCBCRP)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Michael Birnbaum (Arlington, Massachusetts);  Connor Dobson (Somerville, Massachusetts)
ABSTRACT Compositions of retroviruses and methods of using the same for gene delivery, wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.
FILED Wednesday, August 30, 2023
APPL NO 18/458628
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Peptides
C07K 14/005 (20130101)
C07K 14/4748 (20130101)
C07K 14/5437 (20130101)
C07K 14/70532 (20130101)
C07K 14/70539 (20130101)
C07K 16/2803 (20130101)
C07K 2317/622 (20130101)
C07K 2319/02 (20130101)
C07K 2319/035 (20130101)
C07K 2319/60 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/86 (20130101)
C12N 2740/15045 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/505 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061194 Swager et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Timothy Manning Swager (Newton, Massachusetts);  Hadley Sikes Johnson (Arlington, Massachusetts);  Qifan Zhang (Revere, Massachusetts);  Eric Alexander Miller (Somerville, Massachusetts);  Lukas Zeininger (Berlin, Germany);  Ki-Joo Sung (Minneapolis, Minnesota);  Kosuke Yoshinaga (Cambridge, Massachusetts)
ABSTRACT Embodiments described herein may be useful in the detection of analytes. The systems and methods may allow for a relatively simple and rapid way for detecting analytes such as chemical and/or biological analytes and may be useful in numerous applications including sensing, food manufacturing, medical diagnostics, performance materials, dynamic lenses, water monitoring, environmental monitoring, detection of proteins, detection of DNA, among other applications. For example, the systems and methods described herein may be used for determining the presence of a contaminant such as bacteria (e.g., detecting pathogenic bacteria in food and water samples which helps to prevent widespread infection, illness, and even death). Advantageously, the systems and methods described herein may not have the drawbacks in current detection technologies including, for example, relatively high costs, long enrichment steps and analysis times, and/or the need for extensive user training. Another advantageous feature provided by the systems and methods described herein includes fabrication in a relatively large scale. In some embodiments, the systems and methods may be used in conjunction with a detector including handheld detectors incorporated with, for example, smartphones (e.g., for the on-site detection of analytes such as pathogenic bacteria).
FILED Wednesday, December 08, 2021
APPL NO 17/545979
ART UNIT 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/701 (20130101)
C12Q 1/701 (20130101)
C12Q 1/6834 (20130101)
C12Q 2563/159 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/59 (20130101)
G01N 21/77 (20130101)
G01N 21/78 (20130101)
G01N 33/5432 (20130101) Original (OR) Class
G01N 33/54366 (20130101)
G01N 33/56983 (20130101)
G01N 2021/7783 (20130101)
G01N 2201/0221 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061201 Pilch et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Rutgers, The State University of New Jersey (New Brunswick, New Jersey)
ASSIGNEE(S) RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (New Brunswick, New Jersey)
INVENTOR(S) Daniel S. Pilch (New Brunswick, New Jersey);  Edgar Ferrer-González (New Brunswick, New Jersey);  Edmond J. LaVoie (New Brunswick, New Jersey)
ABSTRACT The invention provides a compound of formula I:
or a salt thereof, wherein Y, Z, L, and W have any of the values described in the specification, as well as compositions comprising a compound of formula I or a salt thereof. The compounds are useful as tools for visualizing FtsZ and monitoring cell division in a broad range of Gram-positive and Gram-negative bacterial pathogens of acute clinical importance and for identifying new FtsZ inhibitors.
FILED Monday, September 21, 2020
APPL NO 17/027513
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 5/022 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/52 (20130101)
G01N 33/582 (20130101) Original (OR) Class
G01N 33/56911 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061204 Coon et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
INVENTOR(S) Joshua Coon (Middleton, Wisconsin);  Harald Marx (Madison, Wisconsin)
ABSTRACT In shotgun proteomics, generally only a fraction of peptides from a parent protein are actually detected. Because a large portion of the protein sequence is not detected, it is often impossible to determine whether the expressed protein is present in a modified, spliced, or truncated form. Provided herein are methods and systems for analyzing polypeptides which allow for the increase of the mean sequence coverage of a protein concomitant with bioinformatics analysis in order to distinguish putative proteoforms with improved amino acid resolution. Aspects of the invention include (1) a deep sequencing strategy to provide more protein sequence coverage than is typically achieved, and (2) a computational approach to view protein expression across its full length and identify regions of the protein that are potentially subject to such regulation. This technology has global utility in proteomics and will be of particular use for the analysis of biosimilar protein drug therapeutics.
FILED Thursday, April 15, 2021
APPL NO 17/231977
ART UNIT 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/6824 (20130101)
G01N 33/6842 (20130101)
G01N 33/6848 (20130101) Original (OR) Class
G01N 2570/00 (20130101)

Bioinformatics, i.e Information and Communication Technology [ICT] Specially Adapted for Genetic or Protein-related Data Processing in Computational Molecular Biology
G16B 30/00 (20190201)
G16B 30/20 (20190201)
G16B 40/00 (20190201)
G16B 40/10 (20190201)
G16B 40/30 (20190201)

Electric Discharge Tubes or Discharge Lamps
H01J 49/004 (20130101)
H01J 49/0036 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061248 Juchem et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute of Mental Health (NIMH)
APPLICANT(S) The Trustees of Columbia University in the City of New York (New York, New York)
ASSIGNEE(S) The Trustees of Columbia University in the City of New York (New York, New York)
INVENTOR(S) Christoph Juchem (Ridgefield, Connecticut);  Michael Sebastian Theilenberg (New York, New York);  Yun Shang (New York, New York);  Jalal Ghazouani (Hamburg, Germany)
ABSTRACT An apparatus for fabricating non-planar coils includes a rotating table driven by a first motor; a wire approach height adjustment arm driven by a second motor; and a synchronization module configured such that a wire traversing from the height adjustment arm to a bobbin on the rotating table passes into a non-planar groove cut in the bobbin without damaging the wire. Performing magnetic resonance (MR) measurements includes a plurality of coil units configured for generating a gradient or shim magnetic field. The coil unit includes a plurality of coil windings, and each coil winding is separated longitudinally from an adjacent coil winding. A single pair of electrically conducting leads is configured to cause current to flow through all of the plurality of coil windings in the coil unit. Techniques include methods to fabricate and operate the apparatus.
FILED Monday, January 31, 2022
APPL NO 17/649462
ART UNIT 2863 — Printing/Measuring and Testing
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/3856 (20130101)
G01R 33/3858 (20130101) Original (OR) Class
G01R 33/3875 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061328 Valdes et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) THE TRUSTEES OF DARTMOUTH COLLEGE (Hanover, New Hampshire)
ASSIGNEE(S) THE TRUSTEES OF DARTMOUTH COLLEGE (Hanover, New Hampshire)
INVENTOR(S) Pablo A. Valdes (Hanover, New Hampshire);  David W. Roberts (Lyme, New Hampshire);  Keith D. Paulsen (Hanover, New Hampshire);  Frederic Leblond (Montreal, Canada)
ABSTRACT An imaging system includes an illumination device for illuminating a target. A surgical microscope receives light from the target, the surgical microscope comprising at least one optical output port at which at least a portion of the received light is provided as an output from the surgical microscope. A tunable filter receives the portion of the received light provided as the output from the surgical microscope, the tunable filter being tunable to pass a filtered portion of the received light, the filtered portion of the received light having a plurality of wavelengths selected by the tunable filter and provided as output from the tunable filter. A high-resolution, broad-bandwidth electronic camera receives the light of a plurality of wavelengths selected by the tunable filter, the electronic camera converting the light of a plurality of wavelengths selected by the tunable filter to a plurality of electrical signals. A processor processes the plurality of electrical signals to form an image of the target.
FILED Monday, May 08, 2023
APPL NO 18/144767
ART UNIT 3798 — Printing/Measuring and Testing
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 1/063 (20130101)

Optical Elements, Systems, or Apparatus
G02B 21/06 (20130101) Original (OR) Class
G02B 21/36 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12062178 Wilson et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) Case Western Reserve University (Cleveland, Ohio)
ASSIGNEE(S) Case Western Reserve University (Cleveland, Ohio)
INVENTOR(S) David L. Wilson (Cleveland Heights, Ohio);  Naomi Joseph (Cleveland, Ohio);  Jonathan H. Lass (Cleveland, Ohio);  Beth Ann Benetz (Cleveland, Ohio);  Harry J. Menegay (Cleveland, Ohio);  Elizabeth Fitzpatrick (Nashville, Tennessee)
ABSTRACT Embodiments discussed herein facilitate automated and/or semi-automated segmentation of endothelial cells via a trained deep learning model. One example embodiment is a method, comprising: accessing an optical microscopy image comprising a set of corneal endothelial cells of a patient of a keratoplasty; pre-processing the optical microscopy image to generate a pre-processed optical microscopy image via correcting for at least one of shading or illumination artifacts in the optical microscopy image; segmenting, based at least in part on a trained deep learning (DL) model, a plurality of corneal endothelial cells of the set of corneal endothelial cells in the pre-processed optical microscopy image; and displaying, via a graphical user interface (GUI), at least the segmented plurality of corneal endothelial cells.
FILED Tuesday, January 05, 2021
APPL NO 17/141564
ART UNIT 2671 — Optics
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0621 (20130101)

Optical Elements, Systems, or Apparatus
G02B 21/367 (20130101)

Image Data Processing or Generation, in General
G06T 7/10 (20170101)
G06T 7/11 (20170101) Original (OR) Class
G06T 2207/30024 (20130101)

Image or Video Recognition or Understanding
G06V 10/44 (20220101)
G06V 10/82 (20220101)
G06V 10/764 (20220101)
G06V 20/695 (20220101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12062298 Yates et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) Retivue, LLC (Charlottesville, Virginia)
ASSIGNEE(S) RetiVue, LLC (Charlottesville, Virginia)
INVENTOR(S) Paul A. Yates (Charlottesville, Virginia);  Ming Lai (Pleasanton, California);  Ta-Wei Yi (Pleasanton, California)
ABSTRACT The present invention contemplates an infant eye model for wide field retinal imaging by implementing nominal physical parameters and optical characteristics found in scientific literature and by simulating retinal features and details found in real eye images. The present invention also contemplates implementing a corneal model with a translucent plastic to mimic image haze and 1st Purkinje reflection. The present invention also contemplates implementing a birefringent layer to the lens posterior surface to simulate 4th Purkinje reflection and its brightness variation. The present invention further contemplates implementing a photo-realistic retinal hemisphere shell to provide retinal details and demonstrate retinopathy associated with retinal diseases.
FILED Wednesday, August 16, 2017
APPL NO 16/325781
ART UNIT 2872 — Optics
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 3/14 (20130101)
A61B 3/1173 (20130101)

Educational or Demonstration Appliances; Appliances for Teaching, or Communicating With, the Blind, Deaf or Mute; Models; Planetaria; Globes; Maps; Diagrams
G09B 23/30 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12062422 Min et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) The Trustees of Columbia University in the City of New York (New York, New York)
ASSIGNEE(S) The Trustees of Columbia University in the City of New York (New York, New York)
INVENTOR(S) Wei Min (Fort Lee, New Jersey);  Lingyan Shi (Brooklyn, New York)
ABSTRACT Incorporation of deuterium into the lipids, proteins, and/or genetic material in cells, tissues, organs, or organisms, including animals, such as humans, and plants, by administration of heavy water, allows for the spectral determination of levels of lipids, proteins, and/or genetic material using Raman spectroscopy, such as stimulated Raman spectroscopy. Following administration of a drug, changes in the relative amounts of lipid, protein, and/or genetic materials can be determined, and the efficacy, or lack thereof, of the administered drug can be determined.
FILED Wednesday, January 27, 2021
APPL NO 17/159591
ART UNIT 3686 — Business Methods - Incentive Programs, Coupons; Electronic Shopping; Business Cryptography, Voting; Health Care; Point of Sale, Inventory, Accounting; Business Processing, Electronic Negotiation
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 49/0002 (20130101)
A61K 49/0004 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/65 (20130101)
G01N 33/6848 (20130101)
G01N 2021/656 (20130101)
G01N 2458/15 (20130101)
G01N 2500/10 (20130101)
G01N 2570/00 (20130101)

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 20/10 (20180101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12062436 Ning et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Library of Medicine (NLM)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Information and Intelligent Systems (IIS)
APPLICANT(S) Ohio State Innovation Foundation (Columbus, Ohio);  The Trustees of Indiana University (Bloomington, Indiana)
ASSIGNEE(S) Indiana University Research and Technology Corp. (Bloomington, Indiana);  Ohio State Innovation Foundation (Columbus, Ohio)
INVENTOR(S) Xia Ning (Columbus, Ohio);  Zhiyun Ren (Sunnyvale, California);  Bo Peng (Columbus, Ohio);  Titus K. Schleyer (Indianapolis, Indiana)
ABSTRACT Disclosed embodiments include computer-implemented methods and systems that can efficiently generate highly relevant recommended search terms to clinicians. A hybrid collaborative filtering model recommends search terms for a specific patient to the clinician. The model draws on information from patients' clinical encounters and the searches that were performed during the clinical encounters. To generate recommendations, the model uses search terms which are (1) frequently co-occurring with the ICD codes recorded for the patient and (2) highly relevant to the most recent search terms. One variation of the model uses only the most recent ICD codes assigned to the patient. Another variation uses all ICD codes. Comprehensive experiments of embodiments of the methods and systems have demonstrate high levels of performance.
FILED Monday, November 15, 2021
APPL NO 17/526591
ART UNIT 3686 — Business Methods - Incentive Programs, Coupons; Electronic Shopping; Business Cryptography, Voting; Health Care; Point of Sale, Inventory, Accounting; Business Processing, Electronic Negotiation
CURRENT CPC
Electric Digital Data Processing
G06F 16/24578 (20190101)
G06F 17/16 (20130101)

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 40/20 (20180101) Original (OR) Class
G16H 70/20 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12062444 Conzen et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) THE UNIVERSITY OF CHICAGO (Chicago, Illinois)
ASSIGNEE(S) The University of Chicago (Chicago, Illinois)
INVENTOR(S) Suzanne Conzen (Chicago, Illinois);  Lei Huang (Chicago, Illinois);  Maria Kocherginsky (Chicago, Illinois);  Diana Szymanski (Chicago, Illinois)
ABSTRACT Embodiments are directed to kits and methods of treating a breast cancer patient with a glucocorticoid receptor antagonist with or without an anticancer agent or compound after the patient has been determined to be susceptible to treatment with the glucocorticoid receptor antagonist.
FILED Wednesday, December 12, 2018
APPL NO 16/217350
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6809 (20130101)
C12Q 1/6827 (20130101)
C12Q 1/6837 (20130101)
C12Q 1/6886 (20130101)
C12Q 2600/106 (20130101)
C12Q 2600/112 (20130101)
C12Q 2600/118 (20130101)
C12Q 2600/156 (20130101)
C12Q 2600/158 (20130101)

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 50/20 (20180101) Original (OR) Class
G16H 50/30 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12062926 Babakhani et al.
FUNDED BY
Department of Energy (DOE)
Office of Fossil Energy and Carbon Management (FECM)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Dental and Craniofacial Research (NIDCR)
National Science Foundation (NSF)
Directorate for Social, Behavioral and Economic Sciences (SBE)
Division of Behavioral and Cognitive Sciences (BCS)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Aydin Babakhani (Los Angeles, California);  Hamed Rahmani (Belle Mead, New Jersey);  Hidemasa Mitsui (Santa Clara, California)
ABSTRACT Systems and methods for utilizing a small form-factor, wirelessly powered transceiver are disclosed. In one embodiment, a wireless powered transceiver includes a receive antenna configured to receive a receive signal, a transmit antenna configured to transmit a transmit signal, a power harvesting system including a rectifier circuit configured convert radio frequency energy from the receive signal into DC (direct current) voltage, and a power management unit (PMU) configured to set the operating mode and biasing condition of the receive and transmit circuitry blocks and provide DC voltage from the receive circuitry block to the transmit circuitry block to maintain a minimum voltage, a receiver circuitry block configured to provide energy from the receive signal to the power harvesting system, and a transmitter circuitry block including a data modulator circuit, the data modulator circuit configured to generate the transmit signal using DC voltage received from the power management unit.
FILED Tuesday, September 06, 2022
APPL NO 17/929959
ART UNIT 2836 — Electrical Circuits and Systems
CURRENT CPC
Circuit Arrangements or Systems for Supplying or Distributing Electric Power; Systems for Storing Electric Energy
H02J 50/001 (20200101)
H02J 50/27 (20160201) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US RE50075 Damiano et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) Trustees of Boston University (Boston, Massachusetts)
ASSIGNEE(S) Trustees of Boston University (Boston, Massachusetts)
INVENTOR(S) Edward R. Damiano (Acton, Massachusetts);  Firas H. El-Khatib (Allston, Massachusetts)
ABSTRACT Apparatus and methods calculate and deliver doses of insulin and optionally glucagon into a subject. Online operation controls delivery of correction doses of insulin automatically in response to regular glucose measurements from a sensor, and offline operation calculates and delivers correction doses based on isolated glucose measurements and information gathered autonomously during preceding online operation. In another aspect, offline operation includes automatically calculating and administering meal doses based on information gathered autonomously during preceding periods of online operation. Both methods include generating relevant control parameters tailored to the individual and continually converged upon and potentially modulated during online operation. The control parameters are employed in real time during periods of offline operation to regulate glucose level without the need for user-provided control parameters such as correction factors and insulin-to-carbohydrate ratios.
FILED Thursday, May 06, 2021
APPL NO 17/313401
ART UNIT 3992 — Central Reexamination Unit (Electrical)
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/4839 (20130101)
A61B 5/14532 (20130101)

Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 5/1723 (20130101) Original (OR) Class
A61M 5/16827 (20130101)
A61M 2005/14208 (20130101)
A61M 2005/14296 (20130101)
A61M 2202/07 (20130101)
A61M 2202/0486 (20130101)
A61M 2205/50 (20130101)
A61M 2205/502 (20130101)
A61M 2205/3584 (20130101)
A61M 2230/005 (20130101)
A61M 2230/201 (20130101)

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 15/00 (20180101)
G16H 20/17 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Defense (DOD) 

US 12058996 Toner et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Breast Cancer Research Program (USAMRMCBCRP)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) The General Hospital Corporation (Boston, Massachusetts)
ASSIGNEE(S) The General Hospital Corporation (Boston, Massachusetts)
INVENTOR(S) Mehmet Toner (Charlestown, Massachusetts);  Mustafa Korkut Uygun (Newton, Massachusetts);  Shannon N. Tessier (Framingham, Massachusetts);  Shannon L. Stott (Stoneham, Massachusetts);  Lindong Weng (Arlington, Massachusetts);  Reinier Johan De Vries (Boston, Massachusetts);  Casie A. Pendexter (Rockland, Massachusetts);  Stephanie E J Cronin (Boston, Massachusetts)
ABSTRACT This disclosure is related to methods of preserving biological samples, organs, and organisms. This disclosure is based, at least in part, on the discovery that in the presence of heterogenous extracellular ice, endothelial cells have improved attachment and viability after preservation, and particularly by uniformly nucleating ice across the microvasculature using ice nucleating agents, the chance of intracelluar ice formation can be significantly reduced.
FILED Thursday, June 14, 2018
APPL NO 16/622457
ART UNIT 1638 — SELECT * FROM codes_techcenter;
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 1/0221 (20130101) Original (OR) Class
A01N 1/0294 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059480 Ganesh et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Development Command (USAMRDC)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Breast Cancer Research Program (USAMRMCBCRP)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, New York)
ASSIGNEE(S) MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, New York)
INVENTOR(S) Karuna Ganesh (New York, New York);  Manuel Valiente (Madrid, Spain);  Joan Massague (New York, New York)
ABSTRACT The present invention relates to methods and compositions for inhibiting metastatic spread of cancer and/or inhibiting progression of pre-existing metastatic disease in a subject using L1CAM inhibition.
FILED Monday, October 10, 2022
APPL NO 18/045357
ART UNIT 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/337 (20130101)
A61K 31/519 (20130101)
A61K 45/06 (20130101)
A61K 48/0016 (20130101)
A61K 48/0066 (20130101) Original (OR) Class
A61K 48/0083 (20130101)
A61K 48/0091 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/04 (20180101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101)
C12N 2310/11 (20130101)
C12N 2310/14 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/025 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5011 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059767 Paine et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) The United States of America as represented by the Secretary of the Navy (Keyport, Washington)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Navy (Keyport, Washington)
INVENTOR(S) Tyler Paine (Edmonds, Washington);  Christopher Walther (Gig Harbor, Washington);  Nicholas Johnson (Bremerton, Washington);  Scott Larson (Bremerton, Washington)
ABSTRACT A mechanical assembly to precisely position large objects and align them to be joined with other objects with precision. The assembly does not require power to operate and can therefore be used in a variety of remote and harsh locations.
FILED Friday, January 26, 2024
APPL NO 18/424705
ART UNIT 3799 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Working or Processing of Sheet Metal or Metal Tubes, Rods or Profiles Without Essentially Removing Material; Punching Metal
B21D 39/00 (20130101)

Metal-working Not Otherwise Provided For; Combined Operations; Universal Machine Tools
B23P 19/12 (20130101)

Details, Components, or Accessories for Machine Tools, e.g Arrangements for Copying or Controlling; Machine Tools in General Characterised by the Construction of Particular Details or Components; Combinations or Associations of Metal-working Machines, Not Directed to a Particular Result
B23Q 3/186 (20130101) Original (OR) Class

Tools or Bench Devices Not Otherwise Provided For, for Fastening, Connecting, Disengaging or Holding
B25B 11/02 (20130101)

Motor Vehicles; Trailers
B62D 65/024 (20130101)
B62D 65/026 (20130101)

Ships or Other Waterborne Vessels; Equipment for Shipping
B63B 73/30 (20200101)

Ground or Aircraft-carrier-deck Installations Specially Adapted for Use in Connection With Aircraft; Designing, Manufacturing, Assembling, Cleaning, Maintaining or Repairing Aircraft, Not Otherwise Provided For; Handling, Transporting, Testing or Inspecting Aircraft Components, Not Otherwise Provided for
B64F 5/10 (20170101)

Technical Subjects Covered by Former US Classification
Y10T 29/49895 (20150115)
Y10T 29/53539 (20150115)
Y10T 29/53543 (20150115)
Y10T 29/53548 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059855 Parker et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) U.S. Government as Represented by the Secretary of the Army (Natick, Massachusetts)
ASSIGNEE(S) The United States of America as Represented by the Secretary of the Army (Washington, District of Columbia)
INVENTOR(S) Jason Parker (Grafton, Massachusetts);  Tony Kayhart (Cambridge, Massachusetts);  Damian Kubiak (Marlborough, Massachusetts);  Robert Sykes (Burlington, Massachusetts)
ABSTRACT A method of forming a net shape preform for a high performance ballistic helmet includes preparing one or more full prepreg plies, preparing one or more filler prepreg plies, wherein a shape and orientation of one filler prepreg ply of the one or more filler prepreg plies is different from a shape and orientation of another filler prepreg ply of the one or more filler prepreg plies, layering the one or more full prepreg plies with one or more filler prepreg plies to form a ply stack and deforming a portion of the ply stack while constraining the ply stack by applying in-plane tensional force to the ply stack to form the net-shape preform.
FILED Wednesday, September 23, 2020
APPL NO 17/029117
ART UNIT 1741 — Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
CURRENT CPC
Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 70/56 (20130101) Original (OR) Class
B29C 70/465 (20130101)
B29C 2793/0081 (20130101)

Indexing Scheme Associated With Subclasses B29B, B29C or B29D, Relating to Moulding Materials or to Materials for Reinforcements, Fillers or Preformed Parts, e.g Inserts
B29K 2077/10 (20130101)
B29K 2105/0881 (20130101)
B29K 2307/04 (20130101)

Indexing Scheme Associated With Subclass B29C, Relating to Particular Articles
B29L 2031/768 (20130101)

Armour; Armoured Turrets; Armoured or Armed Vehicles; Means of Attack or Defence, e.g Camouflage, in General
F41H 1/08 (20130101)
F41H 5/0485 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059953 Embler et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) The Boeing Company (Chicago, Illinois)
ASSIGNEE(S) The Boeing Company (Chicago, Illinois)
INVENTOR(S) Jonathan David Embler (Santa Ana, California);  John Matthew Nichols (Madison, Alabama);  Glenn William Torres (Madison, Alabama);  Jacob Ryan Szczudlak (Madison, Alabama);  William Preston Keith (Lakewood, California);  Tin Anh Luu (Garden Grove, California);  Morgan Ashley Lewis (Huntington Beach, California);  Keith Charles Kreutztrager (St. Charles, Missouri);  Jonathan Edward Toomey (Orange, California);  Juan Carlos Guzman (Seattle, Washington)
ABSTRACT A composite tank for a reusable launch vehicle comprises a composite wall, having a first coefficient of thermal expansion. The composite wall comprises a first end, a second end, a central axis, which passes through the first end and through the second end, and a cylindrical interior surface. The composite tank also comprises slosh baffles, formed from a second material, having a second coefficient of thermal expansion that is different from the first coefficient of thermal expansion. Each of the slosh baffles is attached to the cylindrical interior surface of the composite wall. Each of the slosh baffles is annular and is separated from the cylindrical interior surface of the composite wall by a radial gap, selected, in part, based on a difference between the first coefficient of thermal expansion and the second coefficient of thermal expansion. The radial gap is configured to change responsive to changes in temperature of the composite tank.
FILED Wednesday, August 18, 2021
APPL NO 17/405509
ART UNIT 3733 — Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
CURRENT CPC
Arrangement or Mounting of Propulsion Units or of Transmissions in Vehicles; Arrangement or Mounting of Plural Diverse Prime-movers in Vehicles; Auxiliary Drives for Vehicles; Instrumentation or Dashboards for Vehicles; Arrangements in Connection With Cooling, Air Intake, Gas Exhaust or Fuel Supply of Propulsion Units in Vehicles
B60K 15/077 (20130101) Original (OR) Class
B60K 2015/0777 (20130101)
B60K 2015/03486 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060270 Tour et al.
FUNDED BY
Department of Defense (DOD)
APPLICANT(S) William Marsh Rice University (Houston, Texas)
ASSIGNEE(S) William Marsh Rice University (Houston, Texas)
INVENTOR(S) James M. Tour (Bellaire, Texas);  Rodrigo Villegas Salvatierra (Houston, Texas);  Dante Zakhidov (McKinney, Texas);  Junwei Sha (Tianjin, China PRC)
ABSTRACT Embodiments of the present disclosure pertain to methods of making a carbon nanotube hybrid material by depositing a catalyst solution onto a carbon-based material, and growing carbon nanotubes on the carbon-based material such that the grown carbon nanotubes become covalently linked to the carbon-based material through carbon-carbon bonds. The catalyst solution includes a metal component (e.g., iron) and a buffer component (e.g., aluminum) that may be in the form of particles. The metal component of the particle may be in the form of a metallic core or metallic oxide core while the buffer component may be on a surface of the metal component in the form of metal or metal oxides. Further embodiments of the present disclosure pertain to the catalytic particles and carbon nanotube hybrid materials. The carbon nanotube hybrid materials of the present disclosure may be incorporated as electrodes (e.g., anodes or cathodes) in energy storage devices.
FILED Friday, March 06, 2020
APPL NO 16/811183
ART UNIT 1724 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 21/04 (20130101)
B01J 23/72 (20130101)
B01J 23/745 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)
B82Y 40/00 (20130101)

Non-metallic Elements; Compounds Thereof;
C01B 32/16 (20170801)
C01B 32/162 (20170801) Original (OR) Class
C01B 2202/22 (20130101)
C01B 2202/32 (20130101)

Indexing Scheme Relating to Structural and Physical Aspects of Solid Inorganic Compounds
C01P 2006/12 (20130101)

Capacitors; Capacitors, Rectifiers, Detectors, Switching Devices or Light-sensitive Devices, of the Electrolytic Type
H01G 11/36 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/13 (20130101)
H01M 4/96 (20130101)
H01M 4/139 (20130101)
H01M 4/362 (20130101)
H01M 4/0428 (20130101)
H01M 4/583 (20130101)
H01M 4/587 (20130101)
H01M 4/663 (20130101)
H01M 4/9083 (20130101)
H01M 2004/021 (20130101)
H01M 2004/027 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 977/742 (20130101)
Y10S 977/843 (20130101)
Y10S 977/948 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060499 Rowan et al.
FUNDED BY
Department of Defense (DOD)
APPLICANT(S) CASE WESTERN RESERVE UNIVERSITY (Cleveland, Ohio);  THE UNIVERSITY OF CHICAGO (Chicago, Illinois)
ASSIGNEE(S)
INVENTOR(S) Stuart J. Rowan (Chicago, Illinois);  Elvis Cudjoe (Cleveland Heights, Ohio)
ABSTRACT A dynamic cross-linked polymer nanocomposite adhesive has been developed by the oxidation of a thiol functionalized semi-crystalline and/or amorphous oligomer and thiol functionalized Cellulose Nanocrystals (CNCs) to form a polydisulfide network. The resulting solid material has a melting point transition at ca. 75° C. which corresponds to the melting of the semi-crystalline and/or amorphous phase of the nanocomposite adhesive. At higher temperatures (ca. 150° C.), results in the dynamic behavior of the disulfide bond being induced, where the bonds break and reform. Two levels of adhesion are obtained, in some embodiment by (1) heating the adhesive material to 80° C. (melting the semi-crystalline and/or amorphous phase) resulting in a lower modulus/viscosity of the adhesive, thus allowing better surface wetting on a substrate and (2) heating the adhesive material to 150° C. (inducing dynamic behavior of disulfide bonds), further lowers the modulus/viscosity of the adhesive ensuring a much better surface wetting and stronger adhesive bond. The polymer adhesive has been demonstrated to bind to, relatively high surface energy substrates including metal and hydrophilic glass, and to low surface energy substrates such as hydrophobic glass.
FILED Monday, May 07, 2018
APPL NO 16/610985
ART UNIT 1732 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)
B82Y 40/00 (20130101)

Adhesives; Non-mechanical Aspects of Adhesive Processes in General; Adhesive Processes Not Provided for Elsewhere; Use of Materials as Adhesives
C09J 101/08 (20130101) Original (OR) Class
C09J 181/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060559 Niu et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
APPLICANT(S) CZ Biohub SF LLC (San Francisco, California);  The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
ASSIGNEE(S) CZ Biohub SF, LLC (San Francisco, California);  The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
INVENTOR(S) Jia Niu (Stanford, California);  Chelsea Lyons Gordon (Stanford, California);  Hyongsok Tom Soh (San Francisco, California)
ABSTRACT The disclosure is directed to methods and compositions for screening a library of aptamers for aptamers having a binding affinity to a target molecule. Specifically, non-natural nucleotides can be introduced onto aptamers immobilized on the surface of beads. The non-natural nucleotides can then be subsequently chemically modified to include additional binding agents. For example, copper-catalyzed azide-alkyne cycloaddition (CuAAC) reactions can be used to introduce a wide range of binding agents onto non-natural nucleotides on beads.
FILED Wednesday, June 19, 2019
APPL NO 15/734522
ART UNIT 1675 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/115 (20130101) Original (OR) Class
C12N 2310/16 (20130101)
C12N 2320/13 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/686 (20130101)
C12Q 1/6811 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060619 Tavazoie et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Breast Cancer Research Program (USAMRMCBCRP)
APPLICANT(S) The Rockefeller University (New York, New York)
ASSIGNEE(S) THE ROCKEFELLER UNIVERSITY (New York, New York)
INVENTOR(S) Sohail Tavazoie (New York, New York);  Nils Halberg (Brooklyn, New York);  Kim Png (New York, New York)
ABSTRACT This invention concerns pathological angiogenesis and cancer, related treatment methods, and related compositions. Also disclosed are related diagnosis kits and methods.
FILED Monday, January 04, 2021
APPL NO 17/140409
ART UNIT 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/1709 (20130101)
A61K 38/1709 (20130101)
A61K 39/3955 (20130101)
A61K 45/06 (20130101)
A61K 2039/505 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)

Peptides
C07K 16/18 (20130101)
C07K 2317/73 (20130101)
C07K 2317/76 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101)
C12N 15/1135 (20130101)
C12N 2310/113 (20130101)
C12N 2310/141 (20130101)
C12N 2320/11 (20130101)
C12N 2320/12 (20130101)
C12N 2330/31 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101) Original (OR) Class
C12Q 2600/16 (20130101)
C12Q 2600/106 (20130101)
C12Q 2600/118 (20130101)
C12Q 2600/136 (20130101)
C12Q 2600/158 (20130101)
C12Q 2600/178 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060627 Na et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) The Government of the United States of America, as represented by the Secretary of the Navy (Arlington, Virginia)
ASSIGNEE(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Suok-Min Na (Laurel, Maryland);  Nicholas J. Jones (Fairfax, Virginia);  Paul K. Lambert (Columbia, Maryland)
ABSTRACT High entropy alloys (HEAs) are provided, which exhibit hard magnetic properties, including increased saturation magnetization, improved coercivity, and thermal stability at temperatures exceeding about 200° C. Methods of making the HEAs are also provided, as well as methods for using the HEAs, particularly in extreme environments.
FILED Thursday, October 28, 2021
APPL NO 17/513130
ART UNIT 1735 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Alloys
C22C 1/02 (20130101)
C22C 30/02 (20130101) Original (OR) Class

Changing the Physical Structure of Non-ferrous Metals and Non-ferrous Alloys
C22F 1/16 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060852 Nemanick et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
The Aerospace Corporation (AEROSPACE)
Federally Funded Research and Development Center (FFRDC)
Operated by The Aerospace Corporation (AEROSPACE) at El Segundo, CA
APPLICANT(S) The Aerospace Corporation (El Segundo, California)
ASSIGNEE(S) THE AEROSPACE CORPORATION (El Segundo, California)
INVENTOR(S) Eric Joseph Nemanick (Santa Monica, California);  Andrea Hsu (El Segundo, California);  John Schilling (Lancaster, California);  John Desain (Redondo Beach, California);  Brian Brady (Seal Beach, California);  Andrew Cortopassi (Running Springs, California)
ABSTRACT Solid rocket motors are provided herein. In certain embodiments, a solid rocket motor includes a housing containing thin layers of fuel and thin layers of an inert oxidizer, separated by a thin nonconductive layer. The housing has a nozzle at the end for gas release and channeling. Prior to use, the inert oxidizer is activated by electrochemical oxidation which can generate an active oxidizer and additional fuel. Ignition of the oxidizer and fuel can be triggered whereby the contents of the housing can ignite, generating hot gasses to be channeled out through the nozzle to generate thrust. Replacing current state solid rocket motors with embodiments described herein can improve cost, safety and increase capability. The disclosed embodiments can be safe to transport, store, and handle. Additionally, there can be no moving parts unlike hybrid or liquid rocket motors.
FILED Friday, November 12, 2021
APPL NO 17/454691
ART UNIT 3741 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Jet-propulsion Plants
F02K 9/24 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060868 Li et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Asian Office of Aerospace Research and Development (AOARD)
Department of the Navy (DON)
Office of Naval Research (ONR)
Multidisciplinary University Research Initiative (MURI)
Non-Profit Organization (NPO)
Robert A. Welch Foundation
APPLICANT(S) Board of Regents, The University of Texas System (Austin, Texas)
ASSIGNEE(S) The Board of Regents, The University of Texas System (Austin, Texas)
INVENTOR(S) Na Li (Richardson, Texas);  Carter S. Haines (Murphy, Texas);  Marcio D. Lima (Richardson, Texas);  Monica Jung DeAndrade (Richardson, Texas);  Shaoli Fang (Richardson, Texas);  Jiyoung Oh (Richardson, Texas);  Mikhail E. Kozlov (Dallas, Texas);  Dongseok Suh (Plano, Texas);  Ray H. Baughman (Dallas, Texas)
ABSTRACT Actuators (artificial muscles) comprising twisted polymer fibers generate tensile actuation when powered thermally. In some embodiments, the thermally-powered polymer fiber tensile actuator can be incorporated into an article, such as a textile or garment.
FILED Monday, October 18, 2021
APPL NO 17/504305
ART UNIT 3746 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Mechanical Methods or Apparatus in the Manufacture of Artificial Filaments, Threads, Fibres, Bristles or Ribbons
D01D 5/0007 (20130101)

Chemical Features in the Manufacture of Artificial Filaments, Threads, Fibres, Bristles or Ribbons; Apparatus Specially Adapted for the Manufacture of Carbon Filaments
D01F 6/00 (20130101)

Spinning or Twisting
D01H 1/10 (20130101)

Crimping or Curling Fibres, Filaments, Threads, or Yarns; Yarns or Threads
D02G 3/02 (20130101)
D02G 3/26 (20130101)
D02G 3/448 (20130101)

Braiding or Manufacture of Lace, Including Bobbin-net or Carbonised Lace; Braiding Machines; Braid; Lace
D04C 1/02 (20130101)

Indexing Scheme Associated With Sublasses of Section D, Relating to Textiles
D10B 2401/046 (20130101)
D10B 2401/061 (20130101)
D10B 2509/00 (20130101)

Spring, Weight, Inertia or Like Motors; Mechanical-power Producing Devices or Mechanisms, Not Otherwise Provided for or Using Energy Sources Not Otherwise Provided for
F03G 7/06 (20130101) Original (OR) Class

Electric Machines Not Otherwise Provided for
H02N 10/00 (20130101)
H02N 11/006 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 428/2925 (20150115)
Y10T 428/249921 (20150401)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060901 Wiedemeier et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Information Warfare Center (NIWC)
Naval Information Warfare Center Pacific (NIWCPACIFIC)
APPLICANT(S) The United States of America, as represented by the Secretary of the Navy (San Diego, California)
ASSIGNEE(S) United States of America as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Brandon J. Wiedemeier (San Diego, California);  Jeffrey M. Lloyd (San Diego, California);  Salvador Serra (Spring Valley, California)
ABSTRACT A pressure locking clamp includes a base, a hook arm, and a clasp arm. An imaginary central plane divides the base into a first and second half. The hook arm pivots on the first half of the base around a first axis parallel to the imaginary central plane. The clasp arm pivots on the second half of the base around a second axis parallel to the imaginary central plane. The hook and clasp arms each includes a lock contact area. In a closed state of the pressure locking clamp, the hook and clasp arms and the base together form an eye enclosure. In the closed state, pressure inside the eye enclosure presses the lock contact area of the clasp arm against the lock contact area of the hook arm, and this inhibits the hook and clasp arms from pivoting away from each other, reinforcing the eye enclosure.
FILED Tuesday, February 21, 2023
APPL NO 18/172135
ART UNIT 3677 — Wells, Earth Boring/Moving/Working, Excavating, Mining, Harvesters, Bridges, Roads, Petroleum, Closures, Connections, and Hardware
CURRENT CPC
Devices for Fastening or Securing Constructional Elements or Machine Parts Together, e.g Nails, Bolts, Circlips, Clamps, Clips, Wedges, Joints or Jointing
F16B 2/10 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061187 Birnbaum et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Breast Cancer Research Program (USAMRMCBCRP)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Michael Birnbaum (Cambridge, Massachusetts);  Connor Dobson (Somerville, Massachusetts)
ABSTRACT Compositions of retroviruses and methods of using the same for gene delivery, wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.
FILED Monday, March 23, 2020
APPL NO 16/826665
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Peptides
C07K 14/005 (20130101)
C07K 14/4748 (20130101)
C07K 14/5437 (20130101)
C07K 14/70532 (20130101)
C07K 14/70539 (20130101)
C07K 16/2803 (20130101)
C07K 2317/622 (20130101)
C07K 2319/02 (20130101)
C07K 2319/035 (20130101)
C07K 2319/60 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/86 (20130101)
C12N 2740/15045 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/505 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061188 Birnbaum et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Breast Cancer Research Program (USAMRMCBCRP)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Michael Birnbaum (Arlington, Massachusetts);  Connor Dobson (Somerville, Massachusetts)
ABSTRACT Compositions of retroviruses and methods of using the same for gene delivery, wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.
FILED Wednesday, August 30, 2023
APPL NO 18/458628
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Peptides
C07K 14/005 (20130101)
C07K 14/4748 (20130101)
C07K 14/5437 (20130101)
C07K 14/70532 (20130101)
C07K 14/70539 (20130101)
C07K 16/2803 (20130101)
C07K 2317/622 (20130101)
C07K 2319/02 (20130101)
C07K 2319/035 (20130101)
C07K 2319/60 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/86 (20130101)
C12N 2740/15045 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/505 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061260 Russo et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Analog Photonics LLC (Boston, Massachusetts)
ASSIGNEE(S) Analog Photonics LLC (Boston, Massachusetts)
INVENTOR(S) Peter Nicholas Russo (Somerville, Massachusetts);  Christopher Vincent Poulton (Cambridge, Massachusetts);  Matthew Byrd (Arlington, Massachusetts);  Zhan Su (Boston, Massachusetts);  Ehsan Hosseini (Boston, Massachusetts);  Michael Robert Watts (Hingham, Massachusetts)
ABSTRACT At least one beam of an optical wave is transmitted along a transmission angle toward a target location from a send aperture of a transmitter. The optical wave comprises at least a first portion, and a second portion having a different characteristic from a characteristic of the first portion. Two or more receivers include at least one receiver comprising: a receive aperture arranged in proximity to at least one of the send aperture or a receive aperture of a different receiver, an optical phased array within the receive aperture, the optical phased array being configured to receive at least a portion of a collected optical wave arriving at the receive aperture along a respective collection angle, and a filter configured to filter the received portion of the collected optical wave according to the characteristic of the first portion of the optical wave.
FILED Friday, October 28, 2022
APPL NO 17/975834
ART UNIT 3646 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 7/4815 (20130101)
G01S 7/4816 (20130101)
G01S 7/4911 (20130101)
G01S 7/4918 (20130101)
G01S 17/32 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061271 Allen
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
The Aerospace Corporation (AEROSPACE)
Federally Funded Research and Development Center (FFRDC)
Operated by The Aerospace Corporation (AEROSPACE) at El Segundo, CA
APPLICANT(S) The Aerospace Corporation (El Segundo, California)
ASSIGNEE(S) THE AEROSPACE CORPORATION (El Segundo, California)
INVENTOR(S) David W. Allen (Fairfax, Virginia)
ABSTRACT A system and method for periodically varying a center frequency for assured time transfer in order to securely transfer a signal from a source to a receiver, without adding additional encryption to signal.
FILED Thursday, November 18, 2021
APPL NO 17/529657
ART UNIT 3648 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 19/215 (20130101) Original (OR) Class

Radio-controlled Time-pieces
G04R 20/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061673 Soleyman et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) HRL Laboratories, LLC (Malibu, California)
ASSIGNEE(S) HRL LABORATORIES, LLC (Malibu, California)
INVENTOR(S) Sean Soleyman (Calabasas, California);  Deepak Khosla (Camarillo, California)
ABSTRACT Described is a system for controlling multiple autonomous platforms. A training process is performed to produce a trained learning agent in a simulation environment. In each episode, each controlled platform is assigned to one target platform that produces an observation. A learning agent processes the observation using a deep learning network and produces an action corresponding to each controlled platform until an action has been produced for each controlled platform. A reward value is obtained corresponding to the episode. The trained learning agent is executed to control each autonomous platform, where the trained agent receives one or more observations from one or more platform sensors and produces an action based on the one or more observations. The action is then used to control one or more platform actuators.
FILED Wednesday, February 03, 2021
APPL NO 17/167001
ART UNIT 2128 — AI & Simulation/Modeling
CURRENT CPC
Electric Digital Data Processing
G06F 18/2185 (20230101) Original (OR) Class

Computer Systems Based on Specific Computational Models
G06N 3/086 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061977 Nestler et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
APPLICANT(S) Analog Devices, Inc. (Wilmington, Massachusetts)
ASSIGNEE(S) THE TRUSTEES OF PRINCETON UNIVERSITY (Princeton, New Jersey)
INVENTOR(S) Eric G. Nestler (Beach Haven, New Jersey);  Naveen Verma (Princeton, New Jersey);  Hossein Valavi (Princeton, New Jersey)
ABSTRACT Systems and methods are provided for reducing power in in-memory computing, matrix-vector computations, and neural networks. An apparatus for in-memory computing using charge-domain circuit operation includes transistors configured as memory bit cells, transistors configured to perform in-memory computing using the memory bit cells, capacitors configured to store a result of in-memory computing from the memory bit cells, and switches, wherein, based on a setting of each of the switches, the charges on at least a portion of the plurality of capacitors are shorted together. Shorting together the plurality of capacitors yields a computation result.
FILED Friday, February 18, 2022
APPL NO 17/675617
ART UNIT 2123 — AI & Simulation/Modeling
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 3/045 (20230101)
G06N 3/048 (20230101)
G06N 3/061 (20130101)
G06N 3/065 (20230101) Original (OR) Class

Static Stores
G11C 11/54 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061982 O'Shea
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Virginia Tech Intellectual Properties, Inc. (Blacksburg, Virginia)
ASSIGNEE(S) Virginia Tech Intellectual Properties, Inc. (Blacksburg, Virginia)
INVENTOR(S) Timothy James O'Shea (Arlington, Virginia)
ABSTRACT Methods, systems, and apparatus, including computer programs encoded on a storage medium, for processing radio signals. In once aspect, a system is disclosed that includes a processor and a storage device storing computer code that includes operations. The operations may include obtaining first output data generated by a first neural network based on the first neural network processing a received radio signal, receiving, by a signal transformer, a second set of input data that includes (i) the received radio signal and (ii) the first output data, generating, by the signal transformer, data representing a transformed radio signal by applying one or more transforms to the received radio signal, providing the data representing the transformed radio signal to a second neural network, obtaining second output data generated by the second neural network, and determining based on the second output data a set of information describing the received radio signal.
FILED Friday, October 07, 2022
APPL NO 17/962007
ART UNIT 2641 — Telecommunications: Analog Radio Telephone; Satellite and Power Control; Transceivers, Measuring and Testing; Bluetooth; Receivers and Transmitters; Equipment Details
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 3/08 (20130101) Original (OR) Class
G06N 3/045 (20230101)

Transmission
H04B 1/0003 (20130101)
H04B 17/309 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12062174 Usumezbas et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) SRI International (Menlo Park, California)
ASSIGNEE(S) SRI International (Menlo Park, California)
INVENTOR(S) Anil Usumezbas (North Brunswick, New Jersey);  Bogdan Calin Mihai Matei (Princeton, New Jersey);  Rakesh Kumar (West Windsor, New Jersey);  Supun Samarasekera (Skillman, New Jersey)
ABSTRACT A method, machine readable medium and system for semantic segmentation of 3D point cloud data includes determining ground data points of the 3D point cloud data, categorizing non-ground data points relative to a ground surface determined from the ground data points to determine legitimate non-ground data points, segmenting the determined legitimate non-ground and ground data points based on a set of common features, applying logical rules to a data structure of the features built on the segmented determined non-ground and ground data points based on their spatial relationships and incorporated within a machine learning system, and constructing a 3D semantics model from the application of the logical rules to the data structure.
FILED Wednesday, September 15, 2021
APPL NO 17/476377
ART UNIT 2616 — Computer Graphic Processing, 3D Animation, Display Color Attribute, Object Processing, Hardware and Memory
CURRENT CPC
Image Data Processing or Generation, in General
G06T 3/40 (20130101)
G06T 7/10 (20170101) Original (OR) Class
G06T 17/205 (20130101)
G06T 2207/10028 (20130101)
G06T 2207/20072 (20130101)
G06T 2207/20081 (20130101)
G06T 2207/20221 (20130101)
G06T 2207/30181 (20130101)
G06T 2210/56 (20130101)

Image or Video Recognition or Understanding
G06V 10/776 (20220101)
G06V 20/70 (20220101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12062186 Chiu et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Corps of Engineers (USACE)
Engineer Research and Development Center (ERDC)
Geospatial Research Laboratory (GRL)
APPLICANT(S) SRI International (Menlo Park, California)
ASSIGNEE(S) SRI International (Menlo Park, California)
INVENTOR(S) Han-Pang Chiu (West Windsor, New Jersey);  Junjiao Tian (Atlanta, Georgia);  Zachary Seymour (Pennington, New Jersey);  Niluthpol C. Mithun (Lawrenceville, New Jersey);  Alex Krasner (Princeton, New Jersey);  Mikhail Sizintsev (Princeton, New Jersey);  Abhinav Rajvanshi (Plainsboro, New Jersey);  Kevin Kaighn (Medord, New Jersey);  Philip Miller (Yardley, New Jersey);  Ryan Villamil (Plainsboro, New Jersey);  Supun Samarasekera (Skillman, New Jersey)
ABSTRACT A method, machine readable medium and system for RGBD semantic segmentation of video data includes determining semantic segmentation data and depth segmentation data for less than all classes for images of each frame of a first video, determining semantic segmentation data and depth segmentation data for images of each key frame of a second video including a synchronous combination of respective frames of the RGB video and the depth-aware video in parallel to the determination of the semantic segmentation data and the depth segmentation data for each frame of the first video, temporally and geometrically aligning respective frames of the first video and the second video, and predicting semantic segmentation data and depth segmentation data for images of a subsequent frame of the first video based on the determination of the semantic segmentation data and depth segmentation data for images of a key frame of the second video.
FILED Thursday, October 07, 2021
APPL NO 17/496403
ART UNIT 2669 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Image Data Processing or Generation, in General
G06T 3/40 (20130101)
G06T 7/38 (20170101)
G06T 7/50 (20170101)
G06T 7/174 (20170101) Original (OR) Class
G06T 2207/10016 (20130101)
G06T 2207/10024 (20130101)
G06T 2207/20112 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12062732 King et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Materiel Command (AFMC)
Air Force Research Laboratory (AFRL)
APPLICANT(S) The Boeing Company (Chicago, Illinois)
ASSIGNEE(S) THE BOEING COMPANY (Arlington, Virginia)
INVENTOR(S) Richard R. King (Thousand Oaks, California);  Christopher M. Fetzer (Valencia, California);  Daniel C. Law (Arcadia, California);  Xing-Quan Liu (Arcadia, California);  William D. Hong (Los Angeles, California);  Kenneth M. Edmondson (Burbank, California);  Dimitri D. Krut (Encino, California);  Joseph C. Boisvert (Thousand Oaks, California);  Nasser H. Karam (La Canada, California)
ABSTRACT In one aspect, optoelectronic devices are described herein. In some implementations, an optoelectronic device comprises a photovoltaic cell. The photovoltaic cell comprises a space-charge region, a quasi-neutral region, and a low bandgap absorber region (LBAR) layer or an improved transport (IT) layer at least partially positioned in the quasi-neutral region of the cell.
FILED Monday, August 12, 2019
APPL NO 16/538733
ART UNIT 1726 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 31/0352 (20130101)
H01L 31/0687 (20130101)
H01L 31/0725 (20130101) Original (OR) Class
H01L 31/0735 (20130101)
H01L 31/035209 (20130101)
H01L 31/035218 (20130101)
H01L 31/035227 (20130101)
H01L 31/035272 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 10/544 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12063068 Utter et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
The Aerospace Corporation (AEROSPACE)
Federally Funded Research and Development Center (FFRDC)
Operated by The Aerospace Corporation (AEROSPACE) at El Segundo, CA
APPLICANT(S) The Aerospace Corporation (El Segundo, California)
ASSIGNEE(S) THE AEROSPACE CORPORATION (El Segundo, California)
INVENTOR(S) Alexander Clifton Utter (Hawthorne, California);  Chang Lee (Yorba Linda, California)
ABSTRACT A tracking system includes one or more cameras and machine-vision processors configured to track the position of a plurality of optical tracking emitters. Each of the plurality of tracking emitters is modulated with a message. The message includes identification information for any of the plurality of tracking cameras receiving the message, so that the cameras can track the location of each emitter.
FILED Monday, March 08, 2021
APPL NO 17/195529
ART UNIT 2634 — Digital Communications
CURRENT CPC
Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 1/7038 (20190801)

Transmission
H04B 10/11 (20130101)
H04B 10/114 (20130101)
H04B 10/116 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12063073 Estrella
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) Freedom Photonics LLC (Goleta, California)
ASSIGNEE(S) Freedom Photonics LLC (Goleta, California)
INVENTOR(S) Steven Brian Estrella (Santa Barbara, California)
ABSTRACT Various designs of optical interconnects and optical links may comprise one or more optically resonant electro-optical modulators used to modulate one or more optical carriers received from one or more lasers using one or more electronic input signals. A wavelength of each laser may be dynamically tuned using a control signal generated by a feedback control system to stabilize the electro-optical modulation of the optical carriers.
FILED Wednesday, March 23, 2022
APPL NO 17/656193
ART UNIT 2635 — Digital Communications
CURRENT CPC
Transmission
H04B 10/503 (20130101)
H04B 10/572 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12063095 Anderson et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) Gov of the US as Rep by the Secy of the Air Force (Wright Patterson AFB, Ohio)
ASSIGNEE(S) United States of America as represented by the Secretary of the Air Force (Wright-Patterson AFB, Ohio)
INVENTOR(S) Joseph Anderson (Edwards, California);  Nicholas Black (Charlotte, North Carolina);  Michael Anderson (Colorado Springs, Colorado)
ABSTRACT A repeater for maintaining wireless line of sight communications. The repeater is autonomously repositional in both absolute location and azimuthal orientation. The repeater has at least two vibratory motors, or other vibration sources, which provide oscillations to depending legs against a support surface. By selectively operating one or more of the vibration sources together or independently, the repeater may be moved as helpful to maintain line of sight communication with another repeater or other operational hardware. A command signal from a remote base station controls the locomotion of the repeater to provide both a change in absolute position relative to the surroundings and a rotational change in azimuthal orientation as necessary to maintain communication under dynamic conditions.
FILED Monday, October 30, 2023
APPL NO 18/497680
ART UNIT 2644 — Telecommunications: Analog Radio Telephone; Satellite and Power Control; Transceivers, Measuring and Testing; Bluetooth; Receivers and Transmitters; Equipment Details
CURRENT CPC
Transmission
H04B 7/155 (20130101) Original (OR) Class
H04B 7/2606 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Energy (DOE) 

US 12059698 Fedorov
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Basic Energy Sciences (BES)
APPLICANT(S) Georgia Tech Research Corporation (Atlanta, Georgia)
ASSIGNEE(S) Georgia Tech Research Corporation (Atlanta, Georgia)
INVENTOR(S) Andrei G. Fedorov (Atlanta, Georgia)
ABSTRACT Embodiments of the present disclosure provide for methods and systems for making structures using an electrospray system while under vacuum. In particular, embodiments of the present disclosure provide for methods and systems for ultra-fast growth of high aspect ratio nano/meso/micro-structures with three dimensional topological complexity and control of phase and composition of the structure formed.
FILED Tuesday, January 24, 2023
APPL NO 18/158666
ART UNIT 1717 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Spraying Apparatus; Atomising Apparatus; Nozzles
B05B 5/16 (20130101) Original (OR) Class
B05B 5/035 (20130101)
B05B 5/0255 (20130101)

Processes for Applying Fluent Materials to Surfaces, in General
B05D 1/04 (20130101)
B05D 3/068 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 10/00 (20130101)

Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 18/145 (20190501)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059703 Britt et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
APPLICANT(S) MATRIX SENSORS, INC. (San Diego, California)
ASSIGNEE(S) MATRIX SENSORS, INC. (San Diego, California)
INVENTOR(S) David K Britt (El Cerrito, California);  Paul R Wilkinson (El Segundo, California);  Steven Yamamoto (San Diego, California)
ABSTRACT A method is provided for coating a surface of a material with a film of porous coordination polymer. A first substrate having a first surface to be coated is positioned in a processing chamber such that the first surface is placed in an opposing relationship to a second surface. The second surface may be provided by a wall of the processing chamber, or in some cases the second surface may be provided by a second substrate to be coated. The first substrate is held such that a gap exists between the first and second surfaces, and the gap is filled with at least one reaction mixture comprising reagents sufficient to form the crystalline film on at least the first surface. A thin gap (e.g., less than 2 mm) between the first and second surfaces is effective for producing a high quality film having a thickness less than 100 μm. Confining the volume of the reaction mixture to a thin layer adjacent the substrate surface significantly reduces problems with sedimentation and concentration control. The size, shape, or average thickness of the gap may be adjusted during formation of the film in response to feedback from at least one film growth monitor.
FILED Wednesday, September 15, 2021
APPL NO 17/476469
ART UNIT 2899 — Semiconductors/Memory
CURRENT CPC
Apparatus for Applying Fluent Materials to Surfaces, in General
B05C 5/004 (20130101) Original (OR) Class
B05C 5/0225 (20130101)
B05C 11/1005 (20130101)
B05C 13/02 (20130101)
B05C 15/00 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 29/022 (20130101)
G01N 2291/0426 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059727 Elliott et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Oak Ridge National Laboratory (ORNL)
Federally Funded Research and Development Center (FFRDC)
Operated by UT-Battelle, LLC (UTB) at Oak Ridge, TN
APPLICANT(S) UT-Battelle, LLC (Oak Ridge, Tennessee);  NORTH CAROLINA A and T STATE UNIVERSITY (Greensboro, North Carolina)
ASSIGNEE(S) UT-BATTELLE, LLC (Oakridge, Tennessee);  NORTH CAROLINA A and TSTATE UNIVERSITY (Greensboro, North Carolina)
INVENTOR(S) Amelia M. Elliott (Knoxville, Tennessee);  Sun Yi (Greensboro, North Carolina);  Sameer Hamoush (Greensboro, North Carolina);  M A Muktadir (Greensboro, North Carolina);  Sarita Sepulveda (Waynesville, North Carolina)
ABSTRACT Systems and methods for additive manufacturing of objects are disclosed. The system includes an object builder subsystem configured to additively manufacture an object in a powder bed, an object extraction subsystem configured to extract the object from the powder bed, and a depowdering subsystem configured to remove powder from the object while the object is gripped by the gripper assembly. The object extraction subsystem includes a gripper assembly comprising two or more gripper members that each include a perforated mesh structure.
FILED Friday, October 13, 2023
APPL NO 18/379829
ART UNIT 1733 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Working Metallic Powder; Manufacture of Articles From Metallic Powder; Making Metallic Powder
B22F 10/73 (20210101)
B22F 10/85 (20210101)
B22F 12/88 (20210101) Original (OR) Class
B22F 12/90 (20210101)
B22F 2998/10 (20130101)

Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 30/00 (20141201)
B33Y 40/00 (20141201)
B33Y 50/00 (20141201)
B33Y 50/02 (20141201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060272 Xing et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) Yangchuan Xing (Columbia, Missouri);  Ahmed M. Jasim (Columbia, Missouri)
ASSIGNEE(S) THE CURATORS OF THE UNIVERSITY OF MISSOURI (Columbia, Missouri)
INVENTOR(S) Yangchuan Xing (Columbia, Missouri);  Ahmed M. Jasim (Columbia, Missouri)
ABSTRACT A method is disclosed for forming nanoscale coatings on a solid substrate surface. In certain embodiments, the method includes the following steps: contacting a substrate with a first liquid organic solvent; adding a liquid agent to the first liquid organic solvent to form a liquid agent film on a surface of the substrate; and adding the nanocoating precursor in the first liquid organic solvent to react the nanocoating precursor with the liquid agent to form the nanocoating on the surface of the substrate.
FILED Friday, January 11, 2019
APPL NO 16/960214
ART UNIT 1712 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Non-metallic Elements; Compounds Thereof;
C01B 32/168 (20170801) Original (OR) Class

Compounds Containing Metals Not Covered by Subclasses C01D or C01F
C01G 53/42 (20130101)

Indexing Scheme Relating to Structural and Physical Aspects of Solid Inorganic Compounds
C01P 2002/88 (20130101)
C01P 2004/64 (20130101)
C01P 2004/86 (20130101)
C01P 2006/40 (20130101)

Treatment of Inorganic Materials, Other Than Fibrous Fillers, to Enhance Their Pigmenting or Filling Properties; Preparation of Carbon Black;
C09C 1/24 (20130101)
C09C 1/56 (20130101)
C09C 1/3661 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/62 (20130101)
H01M 4/366 (20130101)
H01M 4/523 (20130101)
H01M 10/0525 (20130101)
H01M 2004/028 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060415 Pasqualini et al.
FUNDED BY
Department of Energy (DOE)
Los Alamos National Security, LLC (LANS)
National Nuclear Security Administration (NNSA)
Los Alamos National Laboratory (LANL)
Federally Funded Research and Development Center (FFRDC)
Operated by Triad National Security, LLC (TRIAD) at Los Alamos, NM
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) Rutgers, The State University of New Jersey (New Brunswick, New Jersey)
ASSIGNEE(S) Rutgers, The State University of New Jersey (New Brunswick, New Jersey)
INVENTOR(S) Renata Pasqualini (New Brunswick, New Jersey);  Wadih Arap (New Brunswick, New Jersey);  Fernanda Iamassaki Staquicini (New Brunswick, New Jersey);  Fortunato Ferrara (Santa Fe, New Mexico);  Sara D'Angelo (Santa Fe, New Mexico);  Andrew R. M. Bradbury (Santa Fe, New Mexico)
ABSTRACT Isolated or recombinant EphA5 or GRP78 targeting antibodies are provided. In some cases, antibodies of the embodiments can be used for the detection, diagnosis and/or therapeutic treatment of human diseases, such as cancer. A method of rapidly identifying antibodies or antibody fragments for the treatment of cancer using a combination of in vitro and in vivo methodologies is also provided.
FILED Friday, February 04, 2022
APPL NO 17/592828
ART UNIT 1646 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/07 (20130101)
A61K 39/3955 (20130101)
A61K 39/39558 (20130101)
A61K 47/6803 (20170801)
A61K 47/6817 (20170801)
A61K 47/6843 (20170801)
A61K 47/6849 (20170801)
A61K 47/6891 (20170801)
A61K 49/0008 (20130101)
A61K 2039/505 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Peptides
C07K 14/47 (20130101)
C07K 16/005 (20130101)
C07K 16/18 (20130101) Original (OR) Class
C07K 16/28 (20130101)
C07K 16/30 (20130101)
C07K 16/2866 (20130101)
C07K 16/3023 (20130101)
C07K 2317/21 (20130101)
C07K 2317/35 (20130101)
C07K 2317/55 (20130101)
C07K 2317/73 (20130101)
C07K 2317/77 (20130101)
C07K 2317/622 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/64 (20130101)
C12N 15/1037 (20130101)
C12N 2810/00 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6869 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/574 (20130101)
G01N 33/5011 (20130101)
G01N 33/57423 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060483 Wang et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
APPLICANT(S) Twelve Benefit Corporation (Berkeley, California)
ASSIGNEE(S) Twelve Benefit Corporation (Berkeley, California)
INVENTOR(S) Lihui Wang (Berkeley, California);  Ziyang Huo (Moraga, California);  Chengtian Shen (Irvine, California)
ABSTRACT Provided are compositions including a core moiety and a plurality of polymeric units, in which at least one of these can include an ionizable moiety or an ionic moiety. The core moiety may be a multivalent core moiety, trivalent core moiety, tetravalent core moiety, pentavalent core moiety, or multivalent arylene moiety. Materials, electrochemical cells, and methods using such compositions are also described.
FILED Wednesday, October 20, 2021
APPL NO 17/451630
ART UNIT 1766 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 61/02 (20130101)
C08G 2261/17 (20130101)
C08G 2261/45 (20130101)
C08G 2261/132 (20130101)
C08G 2261/143 (20130101)
C08G 2261/146 (20130101)
C08G 2261/164 (20130101)
C08G 2261/312 (20130101)
C08G 2261/3142 (20130101)
C08G 2270/00 (20130101)

Compositions of Macromolecular Compounds
C08L 65/00 (20130101) Original (OR) Class
C08L 2312/00 (20130101)

Electrolytic or Electrophoretic Processes for the Production of Compounds or Non-metals; Apparatus Therefor
C25B 9/23 (20210101)
C25B 13/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060507 Zaitseva et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) Lawrence Livermore National Security, LLC (Livermore, California)
ASSIGNEE(S) Lawrence Livermore National Security, LLC (Livermore, California)
INVENTOR(S) Natalia P. Zaitseva (Livermore, California);  M Leslie Carman (San Ramon, California);  Andrew M. Glenn (Livermore, California);  Andrew Neil Mabe (Livermore, California)
ABSTRACT A scintillator material includes a polymer matrix, a primary dye in the polymer matrix, the primary dye being a fluorescent dye; a secondary dye, and a Li-containing compound in the polymer matrix, where the Li-containing compound is a Li salt of a short-chain aliphatic acid. In addition, the scintillator material exhibits an optical response signature for thermal neutrons that is different than an optical response signature for fast neutrons.
FILED Thursday, April 08, 2021
APPL NO 17/225429
ART UNIT 1734 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Organic Dyes or Closely-related Compounds for Producing Dyes; Mordants; Lakes
C09B 69/109 (20130101)

Materials for Miscellaneous Applications, Not Provided for Elsewhere
C09K 11/06 (20130101) Original (OR) Class
C09K 2211/1088 (20130101)

Measurement of Nuclear or X-radiation
G01T 1/2006 (20130101)
G01T 1/2033 (20130101)
G01T 3/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061069 Barr et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Kansas City National Security Campus (KCNSC)
NNSA Critical Mission Site
Operated by Honeywell Federal Manufacturing and Technologies, LLC (FM&T) at Kansas City, MO
APPLICANT(S) Honeywell Federal Manufacturing and Technologies, LLC (Kansas City, Missouri)
ASSIGNEE(S) Honeywell Federal Manufacturing and Technologies, LLC (Kansas City, Missouri)
INVENTOR(S) Christian G. Barr (Kansas City, Missouri);  Ben Brown (Kansas City, Missouri);  John Porter (Kansas City, Missouri);  Gregory John Vernon (Kansas City, Missouri)
ABSTRACT A multi-layer armor plate comprises a strike plate, a structural mesh layer, an outer skin, a compliant mesh layer, and an inner skin layer. The strike plate has an outer surface and an inner surface. The structural mesh layer is positioned on the outer surface of the strike plate and includes lattice structure with a first structural compliance. The outer skin layer is positioned over the structural mesh layer. The compliant mesh layer is positioned on the inner surface and includes lattice structure with a second structural compliance that is greater than the first structural compliance. The inner skin layer is positioned over the compliant mesh layer.
FILED Monday, May 02, 2022
APPL NO 17/734589
ART UNIT 3641 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Armour; Armoured Turrets; Armoured or Armed Vehicles; Means of Attack or Defence, e.g Camouflage, in General
F41H 5/0457 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061083 Previsic et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) Re Vision Consulting, LLC (Sacramento, California)
ASSIGNEE(S) RE VISION CONSULTING, LLC (Sacramento, California)
INVENTOR(S) Mirko Previsic (Sacramento, California);  Ravi Challa (Sacramento, California);  Anantha Karthikeyan (Sacramento, California)
ABSTRACT A method and system for prediction of wave properties include collecting time series data streams from one or more wave measurement devices and processing the data using a wave-prediction algorithm to identify the frequency components of the data and compute wave parameters. The wave-field is propagated in space and time to predict wave height, speed, and velocity at a target location. A sliding window approach is used to continuously update the prediction in real-time.
FILED Monday, March 02, 2020
APPL NO 17/435684
ART UNIT 3617 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Measuring Distances, Levels or Bearings; Surveying; Navigation; Gyroscopic Instruments; Photogrammetry or Videogrammetry
G01C 13/002 (20130101) Original (OR) Class

Systems for Controlling or Regulating Non-electric Variables
G05D 1/0206 (20130101)

Electric Digital Data Processing
G06F 30/28 (20200101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061249 Loui et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
APPLICANT(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
ASSIGNEE(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
INVENTOR(S) Hung Loui (Albuquerque, New Mexico);  Brianna N. Maio (Albuquerque, New Mexico);  Steven Castillo (Peralta, New Mexico);  Emmett J. Gurule (Albuquerque, New Mexico)
ABSTRACT Various technologies pertaining to forming a very high instantaneous bandwidth (IBW) radar signal based upon several radio frequency (RF) signals that have sub-bands of the frequency band of the radar signal are described herein. A radar system is configured to address local oscillator leakage across multiple transmit channels of the radar system, such that the radar signal has a relatively constant or other desired amplitude and phase across frequencies of the radar signal. In addition, the radar system is configured to compute a correction signal that pre-distorts each of the sub-frequency channels such that upon combining enables the generation of desired amplitude and phase response across a transmitted pulse.
FILED Tuesday, November 09, 2021
APPL NO 17/522385
ART UNIT 3648 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 7/038 (20130101)
G01S 13/0209 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061365 Neidigk et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
APPLICANT(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
ASSIGNEE(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
INVENTOR(S) Stephen Neidigk (Albuquerque, New Mexico);  Thomas M. Rice (Albuquerque, New Mexico)
ABSTRACT A system or method for a magnetic self-aligning coupling device for a fiber optic cable. The device includes a first end coupling comprising a first magnet and a second magnet. Both magnets include a mating surface and an annular ring defining an axial aperture. The aperture receives a distal end of a segment of fiber optic cable in a tight fit. The fiber optic cable has an exterior sleeve and a fiber core. The fiber core of the first segment and the second segment of the fiber optic cable are axially aligned by magnetic force in the first and second apertures to create a continuous fiber optic path. A method for detecting a security breach of a door using the self-aligning couplings is also described.
FILED Wednesday, February 01, 2023
APPL NO 18/104693
ART UNIT 2874 — Optics
CURRENT CPC
Geophysics; Gravitational Measurements; Detecting Masses or Objects; Tags
G01V 8/16 (20130101)

Optical Elements, Systems, or Apparatus
G02B 6/354 (20130101)
G02B 6/3572 (20130101)
G02B 6/3886 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12062461 Welter
FUNDED BY
Department of Energy (DOE)
Office of Nuclear Energy (DOE-NE)
APPLICANT(S) NuScale Power, LLC (Portland, Oregon)
ASSIGNEE(S) NuScale Power, LLC (Corvallis, Oregon)
INVENTOR(S) Kent Welter (Corvallis, Oregon)
ABSTRACT Supports with integrated sensors for nuclear reactor steam generators, and associated systems and methods, are disclosed. A representative method for forming a nuclear-powered steam generator includes forming an instrumented support, the instrumented support including a carrier portion and a retainer portion, with at least one of the carrier portion or the retainer portion being integrally formed with a sensor via an additive manufacturing process. The method can further include coupling the sensor to a communication link, supporting a helical steam conduit on the instrumented support, and installing the helical steam conduit and the instrumented support in a nuclear reactor. The helical steam conduit is positioned along a primary flow path, which is in turn positioned to circulate a heated primary flow in thermal communication with the helical steam conduit.
FILED Thursday, February 04, 2021
APPL NO 17/168118
ART UNIT 3646 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 10/00 (20141201)

Methods of Steam Generation; Steam Boilers
F22B 1/162 (20130101)

Heat-exchange Apparatus, Not Provided for in Another Subclass, in Which the Heat-exchange Media Do Not Come into Direct Contact
F28D 7/02 (20130101)

Details of Heat-exchange and Heat-transfer Apparatus, of General Application
F28F 9/00 (20130101)

Nuclear Reactors
G21C 15/182 (20130101)
G21C 17/102 (20130101)
G21C 17/112 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12062464 Anderson et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Oak Ridge National Laboratory (ORNL)
Federally Funded Research and Development Center (FFRDC)
Operated by UT-Battelle, LLC (UTB) at Oak Ridge, TN
APPLICANT(S) UT-Battelle, LLC (Oak Ridge, Tennessee)
ASSIGNEE(S) UT-Battelle, LLC (Oak Ridge, Tennessee)
INVENTOR(S) David C. Anderson (Knoxville, Tennessee);  Anibal J. Ramirez-Cuesta (Knoxville, Tennessee);  Matthew B. Stone (Oak Ridge, Tennessee);  Amelia M. Elliott (Cleveland, Tennessee);  Derek H. Siddel (Knoxville, Tennessee)
ABSTRACT Collimators and other components for use in neutron scattering experiments or to provide neutron shielding in nuclear reactors or accelerator based neutron sources are produced by additive manufacturing from neutron absorbing material, such as boron carbide (B4C) or isotopically enriched boron carbide (10B).
FILED Monday, August 01, 2022
APPL NO 17/878172
ART UNIT 1744 — Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
CURRENT CPC
Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 64/153 (20170801)

Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 10/00 (20141201)

Nuclear Reactors
G21C 11/028 (20130101)

Protection Against X-radiation, Gamma Radiation, Corpuscular Radiation or Particle Bombardment; Treating Radioactively Contaminated Material; Decontamination Arrangements Therefor
G21F 1/00 (20130101)

Conversion of Chemical Elements; Radioactive Sources
G21G 4/02 (20130101)

Techniques for Handling Particles or Ionising Radiation Not Otherwise Provided For; Irradiation Devices; Gamma Ray or X-ray Microscopes
G21K 1/046 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12062465 Said et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Argonne National Laboratory (ANL)
Federally Funded Research and Development Center (FFRDC)
Operated by UChicago Argonne, LLC (UCHICAGO) at Argonne, IL
APPLICANT(S) UCHICAGO ARGONNE, LLC (Chicago, Illinois)
ASSIGNEE(S) UCHICAGO ARGONNE, LLC (Chicago, Illinois)
INVENTOR(S) Ayman H. Said (Lombard, Illinois);  Thomas Gog (Woodridge, Illinois);  Jung Ho Kim (Naperville, Illinois);  Emily K. Aran (Westchester, Illinois)
ABSTRACT The invention provides a method for fabricating analyzers, the method comprising providing a radiation manipulating material on a first surface of a flexible support; contacting a second surface of the flexible support to a permeable mold, wherein the mold has a first flexible support contact surface and a second surface; and applying negative pressure to the second side of the flexible support to cause the flexible support to conform to the first flexible support contact surface of the mold. Also provided is a system for fabricating crystal analyzers, the system comprising crystal structures reversibly attached to a flexible support; a porous mold reversibly contacting the flexible support, wherein the mold defines a topography; and a negative pressure applied to the flexible support to cause the crystal structures to conform to the topography.
FILED Friday, August 19, 2022
APPL NO 17/892020
ART UNIT 2884 — Optics
CURRENT CPC
Techniques for Handling Particles or Ionising Radiation Not Otherwise Provided For; Irradiation Devices; Gamma Ray or X-ray Microscopes
G21K 1/06 (20130101) Original (OR) Class
G21K 2201/062 (20130101)
G21K 2201/064 (20130101)
G21K 2201/067 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12062790 Jun et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Lawrence Berkeley National Laboratory (LBNL)
Federally Funded Research and Development Center (FFRDC)
Operated by University of California (UC BERKELEY) at Berkeley, CA
APPLICANT(S) SAMSUNG ELECTRONICS CO., LTD. (Suwon-si, South Korea);  THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S) SAMSUNG ELECTRONICS CO., LTD. (Gyeonggi-Do, South Korea);  THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California);  LAWRENCE BERKELEY NATIONAL LABORATORY (Berkeley, California)
INVENTOR(S) KyuJung Jun (Albany, California);  Gerbrand Ceder (Orinda, California);  Yingzhi Sun (Albany, California);  Yan Wang (Brookline, Massachusetts);  Lincoln Miara (Lincoln, Massachusetts);  Yan Zeng (Albany, California);  Yihan Xiao (Berkeley, California)
ABSTRACT A solid-state ion conductor including a compound of Formula 1:
Li(3+2y1)B(P1-y1A1y1O4)2  Formula 1
wherein, in Formula 1, A1 is an element of Groups 4, 14, or a combination thereof, and has an oxidation state of +4, and 0<y1<1.
FILED Monday, May 17, 2021
APPL NO 17/321714
ART UNIT 1727 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/5825 (20130101) Original (OR) Class
H01M 10/0525 (20130101)
H01M 2004/028 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12062834 Young et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Kansas City National Security Campus (KCNSC)
NNSA Critical Mission Site
Operated by Honeywell Federal Manufacturing and Technologies, LLC (FM&T) at Kansas City, MO
APPLICANT(S) Honeywell Federal Manufacturing and Technologies, LLC (Kansas City, Missouri)
ASSIGNEE(S) Honeywell Federal Manufacturing and Technologies, LLC (Kansas City, Missouri)
INVENTOR(S) Barbara Diane Young (Raymore, Missouri);  Steven James Sedlock (Raymore, Missouri);  Kevin Christopher Ledden (Raymore, Missouri);  Alan Ahlberg Elliot (Lees Summit, Missouri)
ABSTRACT A method for tuning a resonant frequency of wireless communication circuitry on a multichip module including a plurality of chips includes applying an electrical insulator to an upper surface of the multichip module; creating a plurality of openings in the electrical insulator, each opening being positioned at a successive one of the bond pads to be electrically connected to create a plurality of exposed bond pads; applying metal to each exposed bond pad to form a successive one of a plurality of interconnect bases; removing a portion of the layer of photoresist to create a plurality of bridge supports, each bridge support positioned between a successive pair of interconnect bases; applying metal to each bridge support and associated interconnect bases to form a successive one of the interconnect traces; removing the bridge supports; and disconnecting one or more of the interconnect traces as necessary to obtain a target resonant frequency.
FILED Wednesday, September 06, 2023
APPL NO 18/461654
ART UNIT 2845 — Electrical Circuits and Systems
CURRENT CPC
Antennas, i.e Radio Aerials
H01Q 1/38 (20130101)
H01Q 1/422 (20130101)
H01Q 1/2283 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12062926 Babakhani et al.
FUNDED BY
Department of Energy (DOE)
Office of Fossil Energy and Carbon Management (FECM)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Dental and Craniofacial Research (NIDCR)
National Science Foundation (NSF)
Directorate for Social, Behavioral and Economic Sciences (SBE)
Division of Behavioral and Cognitive Sciences (BCS)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Aydin Babakhani (Los Angeles, California);  Hamed Rahmani (Belle Mead, New Jersey);  Hidemasa Mitsui (Santa Clara, California)
ABSTRACT Systems and methods for utilizing a small form-factor, wirelessly powered transceiver are disclosed. In one embodiment, a wireless powered transceiver includes a receive antenna configured to receive a receive signal, a transmit antenna configured to transmit a transmit signal, a power harvesting system including a rectifier circuit configured convert radio frequency energy from the receive signal into DC (direct current) voltage, and a power management unit (PMU) configured to set the operating mode and biasing condition of the receive and transmit circuitry blocks and provide DC voltage from the receive circuitry block to the transmit circuitry block to maintain a minimum voltage, a receiver circuitry block configured to provide energy from the receive signal to the power harvesting system, and a transmitter circuitry block including a data modulator circuit, the data modulator circuit configured to generate the transmit signal using DC voltage received from the power management unit.
FILED Tuesday, September 06, 2022
APPL NO 17/929959
ART UNIT 2836 — Electrical Circuits and Systems
CURRENT CPC
Circuit Arrangements or Systems for Supplying or Distributing Electric Power; Systems for Storing Electric Energy
H02J 50/001 (20200101)
H02J 50/27 (20160201) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12063461 Galambos et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
APPLICANT(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
ASSIGNEE(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
INVENTOR(S) Paul C. Galambos (Albuquerque, New Mexico);  Keith Ortiz (Albuquerque, New Mexico);  Brent T. Meyer (Albuquerque, New Mexico);  Sean Yen (Albuquerque, New Mexico);  Gilbert V. Herrera (Columbia, Maryland);  Anthony L. Lentine (Albuquerque, New Mexico);  Gwendolyn Hummel (Albuquerque, New Mexico);  Robin B. Jacobs-Gedrim (Albuquerque, New Mexico)
ABSTRACT A maze-based switch generally having three functional blocks is disclosed. The first functional block handles communications by accepting an entered maze pattern from an external system controller and outputting the entered maze pattern (and optionally its directional complement) to the second functional block. The second functional block stores the maze pattern (and optionally its directional complement) to a permanent storage element and outputs the stored, entered maze pattern and its directional complement to a series of transistors in the third functional block. The third functional block is an electronic maze in which a correct maze pattern and its directional complement must be received by the transistors for the transistors to pass electrical power through the electronic maze to a connected element. The third functional block may alternatively be implemented with optical elements, optoelectronic elements, microelectromechanical elements, or elements formed by other microsystem technologies.
FILED Monday, November 22, 2021
APPL NO 17/532108
ART UNIT 2685 — Selective Communication
CURRENT CPC
Measuring Not Specially Adapted for a Specific Variable; Arrangements for Measuring Two or More Variables Not Covered in a Single Other Subclass; Tariff Metering Apparatus; Measuring or Testing Not Otherwise Provided for
G01D 5/266 (20130101)

Optical Elements, Systems, or Apparatus
G02B 6/29355 (20130101)

Selecting
H04Q 11/0005 (20130101) Original (OR) Class
H04Q 2011/0035 (20130101)
H04Q 2011/0041 (20130101)
H04Q 2011/0058 (20130101)
H04Q 2213/13003 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12063788 Dowben et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Lawrence Berkeley National Laboratory (LBNL)
Federally Funded Research and Development Center (FFRDC)
Operated by University of California (UC BERKELEY) at Berkeley, CA
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Electrical, Communications and Cyber Systems (ECCS)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (Lincoln, Nebraska);  BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas);  GEORGIA TECH RESEARCH CORPORATION (Atlanta, Georgia);  THE TRUSTEES OF INDIANA UNIVERSITY (Bloomington, Indiana);  THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S) NUTECH VENTURES (Lincoln, Nebraska);  GEORGIA TECH RESEARCH CORPORATION (Atlanta, Georgia);  THE TRUSTEES OF INDIANA UNIVERSITY (Bloomington, Indiana);  BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas);  THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
INVENTOR(S) Peter A. Dowben (Crete, Nebraska);  Ruihua Cheng (Indianapolis, Indiana);  Xiaoshan Xu (Lincoln, Nebraska);  Alpha T. N'Diaye (Berkeley, California);  Aaron Mosey (Indianapolis, Indiana);  Guanhua Hao (Lincoln, Nebraska);  Thilini K. Ekanayaka (Lincoln, Nebraska);  Xuanyuan Jiang (Gainesville, Florida);  Andrew J. Yost (Stillwater, Oklahoma);  Andrew Marshall (Dallas, Texas);  Azad J. Naeemi (Atlanta, Georgia)
ABSTRACT A thin film molecular memory is provided that satisfies criteria needed to make a molecular spintronic device, based on spin crossover complexes, competitive with silicon technology. These criteria include, device implementation, a low coercive voltage (less than 1V) and low write peak currents (on the order of 104 A/cm2), a device on/off ratio >10, thin film quality, the ability to “lock” the spin state (providing nonvolatility), the ability to isothermally “unlock” and switch the spin state with voltage, conductance change with spin state, room temperature and above room temperature operation, an on-state device resistivity less than 1 Ω·cm, a device fast switching speed (less than 100 ps), device endurance (on the order of 1016 switches without degradation), and the ability of having a device with a transistor channel width of 10 nm or below.
FILED Tuesday, January 25, 2022
APPL NO 17/583858
ART UNIT 2815 — Semiconductors/Memory
CURRENT CPC
Static Stores
G11C 11/5607 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 29/516 (20130101)
H01L 29/78391 (20140902)

Electronic Memory Devices
H10B 51/30 (20230201) Original (OR) Class
H10B 61/10 (20230201)
H10B 61/22 (20230201)
VIEW PATENT @ USPTO:  Full Text   PDF 

National Science Foundation (NSF) 

US 12059000 Marenda et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Biological Sciences (BIO)
Division of Integrative Organismal Systems (IOS)
APPLICANT(S) Drexel University (Philadelphia, Pennsylvania)
ASSIGNEE(S) Drexel University (Philadelphia, Pennsylvania)
INVENTOR(S) Daniel R. Marenda (Elkins Park, Pennsylvania);  Sean O'Donnell (Swarthmore, Pennsylvania)
ABSTRACT The disclosure provides a human-safe method of killing or controlling insects using a non-toxic composition comprising erythritol ((2R,3S)-butane-1,2,3,4-tetraol). The disclosure also provides non-toxic compositions comprising erythritol suitable for killing insects in residential, commercial, and agricultural locales.
FILED Thursday, October 20, 2022
APPL NO 17/970184
ART UNIT 1616 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 25/006 (20130101)
A01N 25/10 (20130101)
A01N 25/30 (20130101)
A01N 31/02 (20130101) Original (OR) Class

Biocidal, Pest Repellant, Pest Attractant or Plant Growth Regulatory Activity of Chemical Compounds or Preparations
A01P 7/04 (20210801)
A01P 19/00 (20210801)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059251 Lin et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (New York, New York)
ASSIGNEE(S) THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (New York, New York)
INVENTOR(S) Qiao Lin (New York, New York);  Yibo Zhu (New York, New York);  Junyi Shang (New York, New York);  Zhixing Zhang (New York, New York);  Xuejun Wang (New York, New York);  Jaeyoung Yang (New York, New York);  Cheng Wang (New York, New York);  Zhuang Hao (New York, New York)
ABSTRACT A microdevice for monitoring a target analyte is provided. The microdevice can include a field effect transistor comprising a substrate, a gate electrode, and a microfluidic channel including graphene. The microfluidic channel can be formed between drain electrodes and source electrodes on the substrate. The microdevice can also include at least one aptamer functionalized on a surface of the graphene. The at least one aptamer can be adapted for binding to the target analyte. Binding of the target analyte to the at least one aptamer can alter the conductance of the graphene.
FILED Thursday, March 05, 2020
APPL NO 16/810183
ART UNIT 1798 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/1477 (20130101)
A61B 5/1491 (20130101)
A61B 5/6821 (20130101)
A61B 5/14507 (20130101)
A61B 5/14532 (20130101) Original (OR) Class
A61B 5/14539 (20130101)
A61B 5/14546 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/4145 (20130101)
G01N 27/4146 (20130101)
G01N 33/74 (20130101)
G01N 2333/62 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/0262 (20130101)
H01L 21/02425 (20130101)
H01L 21/02527 (20130101)
H01L 21/02664 (20130101)
H01L 23/38 (20130101)
H01L 29/1606 (20130101)

Organic electric solid-state devices
H10K 10/484 (20230201)
H10K 85/20 (20230201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12059830 Baer et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) CASE WESTERN RESERVE UNIVERSITY (Cleveland, Ohio)
ASSIGNEE(S) CASE WESTERN RESERVE UNIVERSITY (Cleveland, Ohio)
INVENTOR(S) Eric Baer (Cleveland Heights, Ohio);  Andy Olah (Spencer, Ohio);  Zhenpeng Li (Shaker Heights, Ohio);  Michael Hore (Shaker Heights, Ohio);  Cong Zhang (Cleveland, Ohio)
ABSTRACT A security marking has a physically unclonable function (PUF) wherein the PUF includes a disordered multilayer photonic crystal structure having an electromagnetic transmission and/or reflection spectrum and/or spectra upon receipt of electromagnetic radiation within a photonic bandgap region of the structure that is unique to the structure.
FILED Monday, June 06, 2022
APPL NO 17/832892
ART UNIT 2877 — Optics
CURRENT CPC
Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 48/001 (20190201) Original (OR) Class
B29C 48/08 (20190201)
B29C 48/21 (20190201)

Indexing Scheme Associated With Subclasses B29B, B29C or B29D, Relating to Moulding Materials or to Materials for Reinforcements, Fillers or Preformed Parts, e.g Inserts
B29K 2105/0032 (20130101)

Indexing Scheme Associated With Subclass B29C, Relating to Particular Articles
B29L 2007/008 (20130101)

Books; Book Covers; Loose Leaves; Printed Matter Characterised by Identification or Security Features; Printed Matter of Special Format or Style Not Otherwise Provided For; Devices for Use Therewith and Not Otherwise Provided For; Movable-strip Writing or Reading Apparatus
B42D 25/21 (20141001)
B42D 25/45 (20141001)
B42D 25/324 (20141001)
B42D 25/328 (20141001)
B42D 25/378 (20141001)
B42D 25/382 (20141001)
B42D 25/387 (20141001)

Optical Elements, Systems, or Apparatus
G02B 1/04 (20130101)
G02B 5/1814 (20130101)
G02B 2005/1804 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060318 Lu et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Science Foundation (NSF)
Directorate for STEM Education (EDU)
Directorate for Education and Human Resources (EHR)
Division of Graduate Education (DGE)
APPLICANT(S) CASE WESTERN RESERVE UNIVERSITY (Cleveland, Ohio)
ASSIGNEE(S) CASE WESTERN RESERVE UNIVERSITY (Cleveland, Ohio)
INVENTOR(S) Zheng-Rong Lu (Cleveland, Ohio);  Da Sun (Cleveland, Ohio);  Rebecca Schur (Cleveland, Ohio)
ABSTRACT A nanosized complex includes a nucleic acid and a compound comprising formula (I): wherein R1 is an alkylamino group or a group containing at least one aromatic group; R2 and R3 are independently an aliphatic group or hydrophobic group; R4 and R5 are independently H, a substituted or unsubstituted alkyl group, an alkenyl group, an acyl group, or an aromatic group, or a polymer, a targeting group, a detectable moiety, or a linker, or a combination thereof, and at least one of R4 and R5 includes a retinoid or retinoid derivative that targets and/or binds to an interphotoreceptor retinoid binding protein; a, b, c, and d are independently an integer from 1 to 10; and pharmaceutically acceptable salts thereof.
FILED Thursday, July 30, 2020
APPL NO 16/943008
ART UNIT 1699 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/51 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 5/00 (20130101)

Acyclic or Carbocyclic Compounds
C07C 403/10 (20130101) Original (OR) Class
C07C 403/12 (20130101)
C07C 403/14 (20130101)
C07C 403/20 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060398 Sourlis et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) Northeastern University (Boston, Massachusetts)
INVENTOR(S) Arjirios Sourlis (Zurich, Switzerland);  Anna Duraj-Thatte (Kensington, California);  Avinash Manjula Basavanna (Allston, Massachusetts);  Neel Satish Joshi (Somerville, Massachusetts)
ABSTRACT Disclosed herein are engineered bacteria that manufacture biofilms from bacterial amyloid structures. These biofilms and biofilm matrices are capable of generating fibrous proteinaceous networks and being used as 3D-printing inks.
FILED Friday, June 21, 2019
APPL NO 17/254019
ART UNIT 1658 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 15/32 (20130101)
A61L 15/42 (20130101)
A61L 24/0031 (20130101)
A61L 24/108 (20130101)
A61L 27/52 (20130101)
A61L 27/227 (20130101)

Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 70/00 (20141201)

Peptides
C07K 14/75 (20130101)
C07K 14/78 (20130101)
C07K 14/4711 (20130101) Original (OR) Class
C07K 2319/00 (20130101)

Coating Compositions, e.g Paints, Varnishes or Lacquers; Filling Pastes; Chemical Paint or Ink Removers; Inks; Correcting Fluids; Woodstains; Pastes or Solids for Colouring or Printing; Use of Materials Therefor
C09D 11/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060513 Jákli et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Antal Jákli (Kent, Ohio);  W. S. Kelum Perera (Kent, Ohio)
ASSIGNEE(S) KENT STATE UNIVERSITY (Kent, Ohio)
INVENTOR(S) Antal Jákli (Kent, Ohio);  W. S. Kelum Perera (Kent, Ohio)
ABSTRACT The present invention relates to polymer stabilized nematic liquid crystal microlenses. The microlenses can be made from a nematic liquid crystal, a chiral dopant, a reactive monomer, and a photoinitiator. The microlenses can be prepared by spin coating a liquid crystal mixture onto an array including a nickel transmission electron microscope grid. The focal length of the microlens array can be tuned electrically.
FILED Thursday, December 01, 2022
APPL NO 18/073073
ART UNIT 1722 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Materials for Miscellaneous Applications, Not Provided for Elsewhere
C09K 19/14 (20130101)
C09K 19/025 (20130101) Original (OR) Class
C09K 19/586 (20130101)
C09K 19/2021 (20130101)
C09K 2019/122 (20130101)
C09K 2019/0407 (20130101)
C09K 2019/2035 (20130101)
C09K 2323/061 (20200801)

Optical Elements, Systems, or Apparatus
G02B 3/14 (20130101)

Devices or Arrangements, the Optical Operation of Which Is Modified by Changing the Optical Properties of the Medium of the Devices or Arrangements for the Control of the Intensity, Colour, Phase, Polarisation or Direction of Light, e.g Switching, Gating, Modulating or Demodulating; Techniques or Procedures for the Operation Thereof; Frequency-changing; Non-linear Optics; Optical Logic Elements; Optical Analogue/digital Converters
G02F 1/0027 (20130101)
G02F 1/141 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060515 Jakli et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Antal Jakli (Kent, Ohio);  Chenrun Feng (Kent, Ohio)
ASSIGNEE(S) KENT STATE UNIVERSITY (Kent, Ohio)
INVENTOR(S) Antal Jakli (Kent, Ohio);  Chenrun Feng (Kent, Ohio)
ABSTRACT A doped ferroelectric nematic liquid crystal includes a chirality-induced stabilization of the polar nematic order, improved relaxation time for electro-optical switching, and selective reflection in the visible wavelength that is reversibly tunable. The ferroelectric nematic liquid crystal is doped with a chiral dopant selected from benzoic acid, 4-hexyl-,4-[[(1-methylheptyl)oxy]carbonyl]phenyl ester (ZLI811) and BDH1281.
FILED Wednesday, September 21, 2022
APPL NO 17/949516
ART UNIT 1722 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Materials for Miscellaneous Applications, Not Provided for Elsewhere
C09K 19/025 (20130101)
C09K 19/0225 (20130101)
C09K 19/584 (20130101) Original (OR) Class
C09K 2019/2078 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060598 Pfleger et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
APPLICANT(S) WISCONSIN ALUMNI RESEARCH FOUNDATION (Madison, Wisconsin)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
INVENTOR(S) Brian F. Pfleger (Madison, Wisconsin);  Nestor Hernandez-Lozada (Jena, Germany);  Rung-Yi Lai (Changhua, Taiwan)
ABSTRACT Mutant thioesterases having enhanced medium chain substrate activity, polynucleotides encoding and configured to express the mutant thioesterases in a transformed host cell, host cells transformed to contain the polynucleotides, and methods of using same.
FILED Tuesday, July 05, 2022
APPL NO 17/857624
ART UNIT 1651 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/16 (20130101)
C12N 15/52 (20130101)
C12N 15/70 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 7/6409 (20130101) Original (OR) Class

Enzymes
C12Y 301/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061102 Hallstrom et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computer and Network Systems (CNS)
APPLICANT(S) FLORIDA ATLANTIC UNIVERSITY BOARD OF TRUSTEES (Boca Raton, Florida)
ASSIGNEE(S) FLORIDA ATLANTIC UNIVERSITY BOARD OF TRUSTEES (Boca Raton, Florida)
INVENTOR(S) Jason O. Hallstrom (Boca Raton, Florida);  Jiannan Zhai (Boca Raton, Florida);  Chancey Kelley (Lake Worth, Florida);  Michael Brown (San Antonio, Texas);  Andrew Van Zwieten (Huntington Beach, California);  Don Salamon (Piney Point, Maryland)
ABSTRACT Systems and methods for operating a fluid supply system. The methods comprise: using a micro-turbine and an Energy Harvesting Circuit (“EHC”) to harvest energy from a fluid flowing through a pipeline; operating a switch to disconnect the EHC from the micro-turbine when an amount of energy harvested reaches a threshold value; detecting by a sensor device an amount of natural fluid flow through the pipeline while the EHC is disconnected from the micro-turbine; and operating the switch to reconnect the EHC to the micro-turbine after the amount of natural fluid flow has been detected.
FILED Thursday, June 01, 2017
APPL NO 16/610331
ART UNIT 2834 — Electrical Circuits and Systems
CURRENT CPC
Horticulture; Cultivation of Vegetables, Flowers, Rice, Fruit, Vines, Hops or Seaweed; Forestry; Watering
A01G 25/00 (20130101)
A01G 25/16 (20130101)

Machines or Engines for Liquids
F03B 13/10 (20130101)

Measuring Volume, Volume Flow, Mass Flow or Liquid Level; Metering by Volume
G01F 1/075 (20130101) Original (OR) Class
G01F 15/0755 (20130101)

Testing Static or Dynamic Balance of Machines or Structures; Testing of Structures or Apparatus, Not Otherwise Provided for
G01M 3/2807 (20130101)

Dynamo-electric Machines
H02K 7/1823 (20130101)
H02K 11/26 (20160101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061165 Thomas et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Electrical, Communications and Cyber Systems (ECCS)
APPLICANT(S) University of Central Florida Research Foundation, Inc. (Orlando, Florida)
ASSIGNEE(S) University of Central Florida Research Foundation, Inc. (Orlando, Florida)
INVENTOR(S) Jayan Thomas (Orlando, Florida);  Jinxin Li (Orlando, Florida);  Foram Madiyar (Port Orange, Florida)
ABSTRACT One type of plasmonic organic electrochemical transistor (POECT) includes a channel comprising an organic semiconductor, a gate electrode comprising at least one of: an ensemble of nanoparticles and an array of nanostructures, wherein each of the at least one of: an ensemble of nanoparticles and an array of nanostructures comprises localized plasmonic material, an analyte formed at least one of: (a) over the at least one of: the ensemble of nanoparticles and the array of nanostructures and (b) around the at least one of: the ensemble of nanoparticles and the array of nanostructures, wherein an electrolyte is configured to be formed at least one of: between the channel and the gate electrode and over the channel and the gate electrode, a source electrode electrically connected to a first end of the channel; and a drain electrode electrically connected to a second end of the channel which is opposite the first end.
FILED Monday, November 22, 2021
APPL NO 17/532141
ART UNIT 2818 — Semiconductors/Memory
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/4146 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061287 Stillwell et al.
FUNDED BY
National Science Foundation (NSF)
National Center for Atmospheric Research (NCAR)
Federally Funded Research and Development Center (FFRDC)
Operated by University Corporation for Atmospheric Research (UCAR) at Boulder, CO
APPLICANT(S) UNIVERSITY CORPORATION FOR ATMOSPHERIC RESEARCH (Boulder, Colorado);  MONTANA STATE UNIVERSITY (Bozeman, Montana)
ASSIGNEE(S) University Corporation for Atmospheric Research (Boulder, Colorado);  Montana State University (Bozeman, Montana)
INVENTOR(S) Robert Stillwell (Broomfield, Colorado);  Scott Spuler (Westminster, Colorado);  Matthew Hayman (Boulder, Colorado);  Kevin S. Repasky (Bozeman, Montana)
ABSTRACT A beam transmitter, a receiver, and a LIDAR, along with methods to operate each are provided. The beam transmitter comprises a first and a second transmission channel (201a, 201b), each transmission channel including a first online laser, a first offline laser, and a first laser transmission selection switch operable to toggle between including the first online laser signal and the first offline laser signal in a first transmission beam. The beam transmitter further includes at least one light redirection device operable to coalign the first transmission beam with the second transmission beam. The receiver comprises a first splitter (402a, 402b), a first filter (404a, 404b), a first detector channel (406a, 406b), a second splitter (408a, 408b), a second filter (410a, 410b), and a second detector channel (412a, 412b). The LIDAR includes the beam transmitter, the receiver, and a shared telescope.
FILED Friday, November 30, 2018
APPL NO 17/294673
ART UNIT 2855 — Printing/Measuring and Testing
CURRENT CPC
Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 7/484 (20130101)
G01S 7/4815 (20130101) Original (OR) Class
G01S 17/86 (20200101)
G01S 17/95 (20130101)

Devices Using the Process of Light Amplification by Stimulated Emission of Radiation [LASER] to Amplify or Generate Light; Devices Using Stimulated Emission of Electromagnetic Radiation in Wave Ranges Other Than Optical
H01S 5/005 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061407 Yi et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Electrical, Communications and Cyber Systems (ECCS)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Michigan)
ASSIGNEE(S) The Regents of The University of Michigan (Ann Arbor, Michigan)
INVENTOR(S) Ya Sha Yi (Troy, Michigan);  Da Chuan Wu (Ann Arbor, Michigan)
ABSTRACT Beam steering device such as optical phased array (OPA) is a key component in applications of solid-state LIDAR and wireless communication. The traditional single-layer OPA results in a significant energy loss due to the substrate leakage caused by the downward coupling from the grating coupler structure. In the present disclosure, we have investigated a structure based on multi-layers Si3N4/SiO2 platform that can form a 3D OPA to emit the light from the edge of the device with a high efficiency, a 2D converged out-coupling beam will be end-fired to the air. The high efficiency and wide horizontal beam steering are demonstrated numerically, the influence of vertical crosstalk, the delay length, number of waveguide layers, and the fabrication feasibility are also discussed.
FILED Tuesday, March 02, 2021
APPL NO 17/189472
ART UNIT 2874 — Optics
CURRENT CPC
Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 7/4814 (20130101)
G01S 7/4817 (20130101)
G01S 7/4818 (20130101)

Devices or Arrangements, the Optical Operation of Which Is Modified by Changing the Optical Properties of the Medium of the Devices or Arrangements for the Control of the Intensity, Colour, Phase, Polarisation or Direction of Light, e.g Switching, Gating, Modulating or Demodulating; Techniques or Procedures for the Operation Thereof; Frequency-changing; Non-linear Optics; Optical Logic Elements; Optical Analogue/digital Converters
G02F 1/291 (20210101)
G02F 1/292 (20130101) Original (OR) Class
G02F 1/2955 (20130101)
G02F 2201/20 (20130101)
G02F 2203/24 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12061790 Krishnamurthy et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Civil, Mechanical and Manufacturing Innovation (CMMI)
APPLICANT(S) Purdue Research Foundation (West Lafayette, Indiana)
ASSIGNEE(S) Purdue Research Foundation (West Lafayette, Indiana)
INVENTOR(S) Vinayak Raman Krishnamurthy (West Lafayette, Indiana);  Cecil Piya (West Lafayette, Indiana);  Karthik Ramani (West Lafayette, Indiana)
ABSTRACT Some examples provides a set of frameworks, process and methods aimed at enabling the expression and exploration of free-form and parametric 3D shape designs enabled through natural interactions with a hand-held mobile device acting as a controller for 3D virtual objects. A reference plane in a virtual space generated by the location of the mobile device may be used to select a 3D virtual object intersected by the reference plane. Positioning of the mobile device may also be used to control a pointer in the virtual space. In an example, the orientation of the mobile device may be detected by an accelerometer or gyroscope. In example, the position of the mobile device may be detected by a position sensor.
FILED Friday, June 23, 2023
APPL NO 18/340351
ART UNIT 2622 — Selective Visual Display Systems
CURRENT CPC
Electric Digital Data Processing
G06F 3/017 (20130101)
G06F 3/0346 (20130101)
G06F 3/04845 (20130101)
G06F 3/04883 (20130101) Original (OR) Class

Image Data Processing or Generation, in General
G06T 19/006 (20130101)
G06T 19/20 (20130101)
G06T 2219/2016 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12062177 Atria et al.
FUNDED BY
National Science Foundation (NSF)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) nView medical Inc. (Salt Lake City, Utah)
ASSIGNEE(S) nView medical Inc. (Salt Lake City, Utah)
INVENTOR(S) Cristian Atria (Salt Lake City, Utah);  Arvidas B. Cheryauka (Salt Lake City, Utah);  Lisa M. Last (Salt Lake City, Utah)
ABSTRACT Imaging systems comprising x-ray image reconstruction systems combined with optical imaging and/or tracking systems. In some embodiments, the imaging system may comprise an x-ray image reconstruction system configured to generate three-dimensional image data of at least an internal portion of a target object under a surface of the target object and a three-dimensional optical imaging system configured to reconstruct an image of at least a portion of the surface of the target object by generating surface three-dimensional image data. The three-dimensional optical imaging system may be registered to the x-ray tomosynthesis image reconstruction system such that three-dimensional image data from the x-ray tomosynthesis image reconstruction system and three-dimensional image data from the three-dimensional optical imaging system may be used as a constraint to improve image quality of an image of the target object.
FILED Friday, November 20, 2020
APPL NO 17/100097
ART UNIT 2881 — Optics
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 6/032 (20130101)

Image Data Processing or Generation, in General
G06T 7/11 (20170101) Original (OR) Class
G06T 11/006 (20130101)
G06T 2200/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12062436 Ning et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Library of Medicine (NLM)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Information and Intelligent Systems (IIS)
APPLICANT(S) Ohio State Innovation Foundation (Columbus, Ohio);  The Trustees of Indiana University (Bloomington, Indiana)
ASSIGNEE(S) Indiana University Research and Technology Corp. (Bloomington, Indiana);  Ohio State Innovation Foundation (Columbus, Ohio)
INVENTOR(S) Xia Ning (Columbus, Ohio);  Zhiyun Ren (Sunnyvale, California);  Bo Peng (Columbus, Ohio);  Titus K. Schleyer (Indianapolis, Indiana)
ABSTRACT Disclosed embodiments include computer-implemented methods and systems that can efficiently generate highly relevant recommended search terms to clinicians. A hybrid collaborative filtering model recommends search terms for a specific patient to the clinician. The model draws on information from patients' clinical encounters and the searches that were performed during the clinical encounters. To generate recommendations, the model uses search terms which are (1) frequently co-occurring with the ICD codes recorded for the patient and (2) highly relevant to the most recent search terms. One variation of the model uses only the most recent ICD codes assigned to the patient. Another variation uses all ICD codes. Comprehensive experiments of embodiments of the methods and systems have demonstrate high levels of performance.
FILED Monday, November 15, 2021
APPL NO 17/526591
ART UNIT 3686 — Business Methods - Incentive Programs, Coupons; Electronic Shopping; Business Cryptography, Voting; Health Care; Point of Sale, Inventory, Accounting; Business Processing, Electronic Negotiation
CURRENT CPC
Electric Digital Data Processing
G06F 16/24578 (20190101)
G06F 17/16 (20130101)

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 40/20 (20180101) Original (OR) Class
G16H 70/20 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12062926 Babakhani et al.
FUNDED BY
Department of Energy (DOE)
Office of Fossil Energy and Carbon Management (FECM)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Dental and Craniofacial Research (NIDCR)
National Science Foundation (NSF)
Directorate for Social, Behavioral and Economic Sciences (SBE)
Division of Behavioral and Cognitive Sciences (BCS)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Aydin Babakhani (Los Angeles, California);  Hamed Rahmani (Belle Mead, New Jersey);  Hidemasa Mitsui (Santa Clara, California)
ABSTRACT Systems and methods for utilizing a small form-factor, wirelessly powered transceiver are disclosed. In one embodiment, a wireless powered transceiver includes a receive antenna configured to receive a receive signal, a transmit antenna configured to transmit a transmit signal, a power harvesting system including a rectifier circuit configured convert radio frequency energy from the receive signal into DC (direct current) voltage, and a power management unit (PMU) configured to set the operating mode and biasing condition of the receive and transmit circuitry blocks and provide DC voltage from the receive circuitry block to the transmit circuitry block to maintain a minimum voltage, a receiver circuitry block configured to provide energy from the receive signal to the power harvesting system, and a transmitter circuitry block including a data modulator circuit, the data modulator circuit configured to generate the transmit signal using DC voltage received from the power management unit.
FILED Tuesday, September 06, 2022
APPL NO 17/929959
ART UNIT 2836 — Electrical Circuits and Systems
CURRENT CPC
Circuit Arrangements or Systems for Supplying or Distributing Electric Power; Systems for Storing Electric Energy
H02J 50/001 (20200101)
H02J 50/27 (20160201) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12063788 Dowben et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Lawrence Berkeley National Laboratory (LBNL)
Federally Funded Research and Development Center (FFRDC)
Operated by University of California (UC BERKELEY) at Berkeley, CA
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Electrical, Communications and Cyber Systems (ECCS)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (Lincoln, Nebraska);  BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas);  GEORGIA TECH RESEARCH CORPORATION (Atlanta, Georgia);  THE TRUSTEES OF INDIANA UNIVERSITY (Bloomington, Indiana);  THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S) NUTECH VENTURES (Lincoln, Nebraska);  GEORGIA TECH RESEARCH CORPORATION (Atlanta, Georgia);  THE TRUSTEES OF INDIANA UNIVERSITY (Bloomington, Indiana);  BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas);  THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
INVENTOR(S) Peter A. Dowben (Crete, Nebraska);  Ruihua Cheng (Indianapolis, Indiana);  Xiaoshan Xu (Lincoln, Nebraska);  Alpha T. N'Diaye (Berkeley, California);  Aaron Mosey (Indianapolis, Indiana);  Guanhua Hao (Lincoln, Nebraska);  Thilini K. Ekanayaka (Lincoln, Nebraska);  Xuanyuan Jiang (Gainesville, Florida);  Andrew J. Yost (Stillwater, Oklahoma);  Andrew Marshall (Dallas, Texas);  Azad J. Naeemi (Atlanta, Georgia)
ABSTRACT A thin film molecular memory is provided that satisfies criteria needed to make a molecular spintronic device, based on spin crossover complexes, competitive with silicon technology. These criteria include, device implementation, a low coercive voltage (less than 1V) and low write peak currents (on the order of 104 A/cm2), a device on/off ratio >10, thin film quality, the ability to “lock” the spin state (providing nonvolatility), the ability to isothermally “unlock” and switch the spin state with voltage, conductance change with spin state, room temperature and above room temperature operation, an on-state device resistivity less than 1 Ω·cm, a device fast switching speed (less than 100 ps), device endurance (on the order of 1016 switches without degradation), and the ability of having a device with a transistor channel width of 10 nm or below.
FILED Tuesday, January 25, 2022
APPL NO 17/583858
ART UNIT 2815 — Semiconductors/Memory
CURRENT CPC
Static Stores
G11C 11/5607 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 29/516 (20130101)
H01L 29/78391 (20140902)

Electronic Memory Devices
H10B 51/30 (20230201) Original (OR) Class
H10B 61/10 (20230201)
H10B 61/22 (20230201)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Agriculture (USDA) 

US 12060290 Cumbie
FUNDED BY
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
Department of Agriculture (USDA)
National Institute of Food and Agriculture (NIFA)
APPLICANT(S) PANCOPIA, INC (Hampton, Virginia)
ASSIGNEE(S) PANCOPIA, INC (Hampton, Virginia)
INVENTOR(S) William E Cumbie (Newport News, Virginia)
ABSTRACT A method and system to significantly reduce odor emissions caused by ammonia and other noxious gasses and reduce nitrogen levels in animal husbandry wastewater effectively and efficiently by the use of flush water that has been biochemically conditioned to lower the pH thus reducing the level of un-ionized compounds including NH3 which can volatilize into the atmosphere and which method and system can also be used to remove ammonia and nitrogen from the wastewater system. The present disclosure includes the use of flush water that has been biochemically conditioned to lower its pH thus sequestering non-ionized ammonia from being released from a liquid as ammonia gas. This disclosure relates to the new use of nitrification for biochemical conditioning of wastewater for use as flush water to reduce atmospheric ammonia emissions.
FILED Monday, September 21, 2020
APPL NO 17/027343
ART UNIT 1779 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Planting; Sowing; Fertilising
A01C 3/023 (20130101)

Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/5281 (20130101)
C02F 3/006 (20130101)
C02F 3/303 (20130101) Original (OR) Class
C02F 2001/007 (20130101)
C02F 2101/16 (20130101)
C02F 2103/20 (20130101)
C02F 2209/06 (20130101)
C02F 2303/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060403 Rowland et al.
FUNDED BY
Department of Agriculture (USDA)
National Institute of Food and Agriculture (NIFA)
APPLICANT(S) Kansas State University Research Foundation (Manhattan, Kansas)
ASSIGNEE(S) Kansas State University Research Foundation (Manhattan, Kansas)
INVENTOR(S) Raymond R. R. Rowland (Manhattan, Kansas);  Ana Stoian (Manhattan, Kansas)
ABSTRACT The present disclosure provides compositions and methods for decreasing permissiveness to infection by PRRSV. The methods involve inserting peptides or oligopeptides into the CD163 SRCR domain 5 to disrupt the protein structure and thereby prevent PRRSV infection. The deletion of the exon 13 region of PSTII eliminates infection. The replacement of cysteine residues with alanines in SRCR5 as a means to disrupt disulfide bond formation. The final method is the deletion of, or amino acid substitution within the SRCR4-5 interdomain region.
FILED Tuesday, October 16, 2018
APPL NO 16/756756
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 67/027 (20130101)

Peptides
C07K 14/705 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/85 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060565 Callahan et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) The United States of America, as represented by The Secretary of Agriculture (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as Represented by the Secretary of Agriculture (Washington, District of Columbia)
INVENTOR(S) Ann M. Callahan (Shepherdstown, West Virginia);  Christopher D. Dardick (Charles Town, West Virginia)
ABSTRACT The disclosure relates to polynucleotides comprising an endocarp-specific promoter sequence from the peach peroxidase (POX) gene operably linked to a heterologous nucleotide sequence encoding a product of interest. The polynucleotides can be used to specifically alter endosperm gene expression in fruit. In a transgenic cell, the polynucleotides may block formation of phenylpropanoid pathway lignin-pathway precursors, formation of lignin monomers, and/or polymerization of lignin monomers.
FILED Wednesday, March 15, 2023
APPL NO 18/184404
ART UNIT 1663 — Plants
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/8234 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12060679 Tisserat et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) Bradley University (Peoria, Illinois);  The United States of America, as represented by the Secretary of Agriculture (Washington, District of Columbia)
ASSIGNEE(S) Bradley University (Peoria, Illinois)
INVENTOR(S) Brent Tisserat (Washington, Illinois);  Luke Haverhals (Peoria, Illinois);  Zengshe Liu (Morton, Illinois)
ABSTRACT Unique, inexpensive, and. strong biocomposites are obtained from blending cellulose matrix materials pith lignocellulosic reinforcement materials with the aid of alkaline aqueous solvent and cold temperatures. These lignocellulosic composites (LCs) are produced without use of any thermoplastic resins, adhesives, catalysts, plasticizers or d chemical or physical procedures. The LCs include a matrix and a reinforcement material. The matrix is a cellulose material (e.g., cotton, hemp, flax, or wood) that is liquefied using an aqueous alkaline solvent solution under cold temperatures to more readily adhere and or incorporate/encapsulate the lignocellulosic reinforcements (wood chips, fibers, and other lignocellulosic sources).
FILED Thursday, March 25, 2021
APPL NO 17/212345
ART UNIT 1787 — Miscellaneous Articles, Stock Material
CURRENT CPC
Compositions of Macromolecular Compounds
C08L 97/02 (20130101)
C08L 2201/06 (20130101)

Production of Cellulose by Removing Non-cellulose Substances From Cellulose-containing Materials; Regeneration of Pulping Liquors; Apparatus Therefor
D21C 3/02 (20130101)
D21C 3/20 (20130101)
D21C 3/022 (20130101) Original (OR) Class
D21C 3/22 (20130101)
D21C 5/00 (20130101)
D21C 5/022 (20130101)

Pulp Compositions; Preparation Thereof Not Covered by Subclasses D21C or D21D; Impregnating or Coating of Paper; Treatment of Finished Paper Not Covered by Class B31 or Subclass D21G; Paper Not Otherwise Provided for
D21H 11/12 (20130101)
D21H 11/14 (20130101)
D21H 21/18 (20130101)
D21H 21/34 (20130101)
D21H 21/36 (20130101)

Fibreboard; Manufacture of Articles From Cellulosic Fibrous Suspensions or From Papier-mache
D21J 3/00 (20130101)
D21J 5/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Small Business Administration (SBA) 

US 12060290 Cumbie
FUNDED BY
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
Department of Agriculture (USDA)
National Institute of Food and Agriculture (NIFA)
APPLICANT(S) PANCOPIA, INC (Hampton, Virginia)
ASSIGNEE(S) PANCOPIA, INC (Hampton, Virginia)
INVENTOR(S) William E Cumbie (Newport News, Virginia)
ABSTRACT A method and system to significantly reduce odor emissions caused by ammonia and other noxious gasses and reduce nitrogen levels in animal husbandry wastewater effectively and efficiently by the use of flush water that has been biochemically conditioned to lower the pH thus reducing the level of un-ionized compounds including NH3 which can volatilize into the atmosphere and which method and system can also be used to remove ammonia and nitrogen from the wastewater system. The present disclosure includes the use of flush water that has been biochemically conditioned to lower its pH thus sequestering non-ionized ammonia from being released from a liquid as ammonia gas. This disclosure relates to the new use of nitrification for biochemical conditioning of wastewater for use as flush water to reduce atmospheric ammonia emissions.
FILED Monday, September 21, 2020
APPL NO 17/027343
ART UNIT 1779 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Planting; Sowing; Fertilising
A01C 3/023 (20130101)

Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/5281 (20130101)
C02F 3/006 (20130101)
C02F 3/303 (20130101) Original (OR) Class
C02F 2001/007 (20130101)
C02F 2101/16 (20130101)
C02F 2103/20 (20130101)
C02F 2209/06 (20130101)
C02F 2303/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 12062177 Atria et al.
FUNDED BY
National Science Foundation (NSF)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) nView medical Inc. (Salt Lake City, Utah)
ASSIGNEE(S) nView medical Inc. (Salt Lake City, Utah)
INVENTOR(S) Cristian Atria (Salt Lake City, Utah);  Arvidas B. Cheryauka (Salt Lake City, Utah);  Lisa M. Last (Salt Lake City, Utah)
ABSTRACT Imaging systems comprising x-ray image reconstruction systems combined with optical imaging and/or tracking systems. In some embodiments, the imaging system may comprise an x-ray image reconstruction system configured to generate three-dimensional image data of at least an internal portion of a target object under a surface of the target object and a three-dimensional optical imaging system configured to reconstruct an image of at least a portion of the surface of the target object by generating surface three-dimensional image data. The three-dimensional optical imaging system may be registered to the x-ray tomosynthesis image reconstruction system such that three-dimensional image data from the x-ray tomosynthesis image reconstruction system and three-dimensional image data from the three-dimensional optical imaging system may be used as a constraint to improve image quality of an image of the target object.
FILED Friday, November 20, 2020
APPL NO 17/100097
ART UNIT 2881 — Optics
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 6/032 (20130101)

Image Data Processing or Generation, in General
G06T 7/11 (20170101) Original (OR) Class
G06T 11/006 (20130101)
G06T 2200/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Homeland Security (DHS) 

US 12062228 Fry
FUNDED BY
Department of Homeland Security (DHS)
APPLICANT(S) The Government of the United States of America, as represented by the Secretary of Homeland Security (Washington, District of Columbia)
ASSIGNEE(S) The Government of the United States of America, represented by the Secretary of Homeland Security (Washington, District of Columbia)
INVENTOR(S) Mark Fry (Marco Island, Florida)
ABSTRACT Systems and methods of detecting a vortex made by a travelling object is disclosed. In some configurations, a graphic recognition algorithm and vortex similarity engine are used to determine whether a visual media file captured by a media collector contains a vortex. The vortex similarity engine may be configured to determine or identify certain properties about the travelling object based on the travelling object vortex. In some configurations, a computer may trigger an alert if a travelling object vortex is not expected to be in the visual media file.
FILED Thursday, November 02, 2023
APPL NO 18/386410
ART UNIT 2668 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Image or Video Recognition or Understanding
G06V 10/761 (20220101)
G06V 10/776 (20220101) Original (OR) Class
G06V 20/52 (20220101)
G06V 2201/08 (20220101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Justice (DOJ) 

US 12061217 Vabnick et al.
FUNDED BY
Department of Justice (DOJ)
Federal Bureau of Investigation (FBI)
APPLICANT(S) Federal Bureau of Investigation (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as Represented by the Federal Bureau of Investigation, Department of Justice (Washington, District of Columbia)
INVENTOR(S) Ian B. Vabnick (Fredericksburg, Virginia);  Michael Malone (Quantico, Virginia)
ABSTRACT Circuit test devices and methods are provided. The method includes measuring a voltage between first and second conductor points (CPs) of a circuit under test (CUT), and determining if the measured voltage is less than a low voltage threshold value (LVTV) indicative of electrical continuity (EC) between the first and second CPs. In response to determining that the measured voltage is less than the LVTV, the method includes: transmitting a test signal (TS) to the first or second CP, and determining if the test signal is received after being transmitted. In response to determining that the TS is received, a presence of EC between the first and second conductor points is reported, and in response to determining that the TS is not received, absence of EC between the first and second CPs, or a lack of electrical contact between the VMC and the first and/or second CP(s), is reported.
FILED Tuesday, November 29, 2022
APPL NO 18/071415
ART UNIT 2858 — Printing/Measuring and Testing
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 19/16504 (20130101) Original (OR) Class
G01R 19/16528 (20130101)
G01R 31/54 (20200101)
G01R 31/58 (20200101)
G01R 31/3277 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Transportation (USDOT) 

US 12062375 Wei
FUNDED BY
Department of Transportation (USDOT)
Federal Aviation Administration (FAA)
APPLICANT(S) The MITRE Corporation (McLean, Virginia)
ASSIGNEE(S) The MITRE Corporation (McLean, Virginia)
INVENTOR(S) Yuan-Jun Wei (Broadlands, Virginia)
ABSTRACT Disclosed herein are systems and methods for processing an audio file to perform audio Segmentation and Speaker Role Identification (SRID) by training low level classifier and high level clustering components to separate and identify audio from different sources in an audio file by unifying audio separation and automatic speech recognition (ASR) techniques in a single system. Segmentation and SRID can include separating audio in an audio file into one or more segments, based on a determination of the identity of the speaker, category of the speaker, or source of audio in the segment. In one or more examples, the disclosed systems and methods use machine learning and artificial intelligence technology to determine the source of segments of audio using a combination of acoustic and language information. In some examples, the acoustic and language information is used to classify audio in each frame and cluster the audio into segments.
FILED Wednesday, December 08, 2021
APPL NO 17/545710
ART UNIT 2659 — Linguistics, Speech Processing and Audio Compression
CURRENT CPC
Speech Analysis or Synthesis; Speech Recognition; Speech or Voice Processing; Speech or Audio Coding or Decoding
G10L 15/18 (20130101)
G10L 15/063 (20130101)
G10L 17/18 (20130101) Original (OR) Class
G10L 2015/0631 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Veterans Affairs (DVA) 

US 12060396 Pozzi et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) Vanderbilt University (Nashville, Tennessee);  The United States as Represented by The Department of Veterans Affairs (Washington, District of Columbia)
ASSIGNEE(S) Vanderbilt University (Nashville, Tennessee);  The United States as Represented by the Department of Veterans Affairs (Washington, District of Columbia)
INVENTOR(S) Ambra A. Pozzi (Nashville, Tennessee);  Manuel Chiusa (Nashville, Tennessee);  Jack J. Hawiger (Nashville, Tennessee);  Jozef Zienkiewicz (Nashville, Tennessee)
ABSTRACT Disclosed herein are compositions and methods for inhibiting collagen production mediated by the Fused in Sarcoma (FUS) ribonucleoprotein. As disclosed herein, the C terminal domain of FUS contains an uncommon nuclear localization sequence (NLS) motif called PY-NLS that binds the nuclear import receptor transportin. Phosphorylation of FUS leads to its association with transportin and nuclear translocation with consequent increased in collagen production. Therefore, disclosed herein is an isolated peptide having a transportin-binding moiety, which inhibits FUS from binding transportin, linked to a membrane translocating motif. These compositions and methods can be used to inhibit FUS-mediated collagen production, and treat fibrotic disease involving FUS-mediated collagen accumulation in kidneys and other organs displaying fibrotic diseases.
FILED Monday, January 29, 2018
APPL NO 16/481128
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/1709 (20130101)
A61K 38/1777 (20130101)
A61K 38/1825 (20130101)
A61K 45/06 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 13/12 (20180101)

Peptides
C07K 14/50 (20130101)
C07K 14/4703 (20130101) Original (OR) Class
C07K 14/70557 (20130101)
C07K 2319/02 (20130101)
C07K 2319/10 (20130101)
C07K 2319/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

National Aeronautics and Space Administration (NASA) 

US 12062297 Buras et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) TIENOVIX, LLC (Houston, Texas)
ASSIGNEE(S) Tienovix, LLC (Houston, Texas)
INVENTOR(S) William R. Buras (Friendswood, Texas);  Craig S. Russell (League City, Texas);  Kyle Q. Nguyen (League City, Texas)
ABSTRACT Methods for providing real-time, three-dimensional (3D) augmented reality (AR) feedback guidance to a user of an equipment system for training or improved performance, including comparing sensed, real-time user positioning data and data received from the equipment system during use to reference positioning and procedure outcome data, and generating and providing to a user real-time position-based and outcome-based 3D AR feedback based on comparing the sensed and reference data.
FILED Wednesday, May 17, 2023
APPL NO 18/318769
ART UNIT 3715 — Amusement and Education Devices
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 8/06 (20130101)
A61B 8/52 (20130101)
A61B 8/085 (20130101)
A61B 8/466 (20130101)
A61B 8/467 (20130101)
A61B 8/4245 (20130101)
A61B 8/4254 (20130101)
A61B 8/4263 (20130101)
A61B 34/20 (20160201)
A61B 90/361 (20160201)
A61B 2034/2048 (20160201)
A61B 2034/2055 (20160201)
A61B 2090/365 (20160201)
A61B 2090/378 (20160201)
A61B 2090/3945 (20160201)
A61B 2562/0219 (20130101)

Optical Elements, Systems, or Apparatus
G02B 27/017 (20130101)

Electric Digital Data Processing
G06F 3/011 (20130101)
G06F 3/016 (20130101)

Computer Systems Based on Specific Computational Models
G06N 20/00 (20190101)

Educational or Demonstration Appliances; Appliances for Teaching, or Communicating With, the Blind, Deaf or Mute; Models; Planetaria; Globes; Maps; Diagrams
G09B 5/065 (20130101)
G09B 23/286 (20130101) Original (OR) Class

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 30/20 (20180101)
G16H 40/63 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Non-Profit Organization (NPO) 

US 12060868 Li et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Asian Office of Aerospace Research and Development (AOARD)
Department of the Navy (DON)
Office of Naval Research (ONR)
Multidisciplinary University Research Initiative (MURI)
Non-Profit Organization (NPO)
Robert A. Welch Foundation
APPLICANT(S) Board of Regents, The University of Texas System (Austin, Texas)
ASSIGNEE(S) The Board of Regents, The University of Texas System (Austin, Texas)
INVENTOR(S) Na Li (Richardson, Texas);  Carter S. Haines (Murphy, Texas);  Marcio D. Lima (Richardson, Texas);  Monica Jung DeAndrade (Richardson, Texas);  Shaoli Fang (Richardson, Texas);  Jiyoung Oh (Richardson, Texas);  Mikhail E. Kozlov (Dallas, Texas);  Dongseok Suh (Plano, Texas);  Ray H. Baughman (Dallas, Texas)
ABSTRACT Actuators (artificial muscles) comprising twisted polymer fibers generate tensile actuation when powered thermally. In some embodiments, the thermally-powered polymer fiber tensile actuator can be incorporated into an article, such as a textile or garment.
FILED Monday, October 18, 2021
APPL NO 17/504305
ART UNIT 3746 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Mechanical Methods or Apparatus in the Manufacture of Artificial Filaments, Threads, Fibres, Bristles or Ribbons
D01D 5/0007 (20130101)

Chemical Features in the Manufacture of Artificial Filaments, Threads, Fibres, Bristles or Ribbons; Apparatus Specially Adapted for the Manufacture of Carbon Filaments
D01F 6/00 (20130101)

Spinning or Twisting
D01H 1/10 (20130101)

Crimping or Curling Fibres, Filaments, Threads, or Yarns; Yarns or Threads
D02G 3/02 (20130101)
D02G 3/26 (20130101)
D02G 3/448 (20130101)

Braiding or Manufacture of Lace, Including Bobbin-net or Carbonised Lace; Braiding Machines; Braid; Lace
D04C 1/02 (20130101)

Indexing Scheme Associated With Sublasses of Section D, Relating to Textiles
D10B 2401/046 (20130101)
D10B 2401/061 (20130101)
D10B 2509/00 (20130101)

Spring, Weight, Inertia or Like Motors; Mechanical-power Producing Devices or Mechanisms, Not Otherwise Provided for or Using Energy Sources Not Otherwise Provided for
F03G 7/06 (20130101) Original (OR) Class

Electric Machines Not Otherwise Provided for
H02N 10/00 (20130101)
H02N 11/006 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 428/2925 (20150115)
Y10T 428/249921 (20150401)
VIEW PATENT @ USPTO:  Full Text   PDF 

United States Postal Service (USPS) 

US 12062008 Turner et al.
FUNDED BY
United States Postal Service (USPS)
APPLICANT(S) United States Postal Service (Washington, District of Columbia)
ASSIGNEE(S) United States Postal Service (Washington, District of Columbia)
INVENTOR(S) Alison Frankowski Turner (Arlington, Virginia);  Marc D. McCrery (Arlington, Virginia);  James J. Boldt (Leesburg, Virginia)
ABSTRACT Methods and systems for coordinating item delivery are disclosed. In one aspect, a method comprises receiving delivery route data from a carrier device, generating, based on the delivery route data, a digital route for a delivery resource, the digital route comprising a street portion and an office portion, wherein the street portion comprises: a plurality of delivery points at which the carrier is to perform a service, and a segmented travel course for the carrier to travel to each of the plurality of delivery points in a determined sequence, and wherein the office portion comprises details regarding one or more office activities performed by the carrier to prepare for or conclude the street portion of a delivery route. The method further comprises determining an expected duration of time for: (1) travel of each segment of the travel course, (2) completion of each of the street activities, and (3) completion of the one or more office activities.
FILED Thursday, April 16, 2020
APPL NO 16/850970
ART UNIT 3628 — Business Methods - Incentive Programs, Coupons; Operations Research; Electronic Shopping; Health Care; Point of Sale, Inventory, Accounting; Cost/ Price, Reservations, Shipping and Transportation; Business Processing
CURRENT CPC
Data Processing Systems or Methods, Specially Adapted for Administrative, Commercial, Financial, Managerial, Supervisory or Forecasting Purposes; Systems or Methods Specially Adapted for Administrative, Commercial, Financial, Managerial, Supervisory or Forecasting Purposes, Not Otherwise Provided for
G06Q 10/0838 (20130101)
G06Q 10/08355 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Government Rights Acknowledged 

How To Use This Page 

THE FEDINVENT PATENT DETAILS PAGE

Each week, FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding by the US Federal Government. The FedInvent Patent Details page is a companion to the weekly FedInvents Patents Report.

This week's information is published in the FedInvent Patents report for Tuesday, August 13, 2024.

The FedInvent Weekly Patent Details Page contains a subset of patent information to provide a deeper dive into the week’s taxpayer-funded patents to help the reader better understand where a patent fits in the federal innovation ecosphere.

HOW IS THE INFORMATION ORGANIZED?

Patents are organized by the funding agency. Within each group, the patents are organized in numeric order. A patent funded by more than one agency will appear in the section of each of the agencies that funded the research and development that resulted in the invention. This approach gives the reader a complete view of the department or agency activity for the week.

WHAT INFORMATION WILL I FIND?

THE PANEL
There is a panel for each patent that contains the patent number and the title of the patent. When you click the panel, it opens to reveal the following information:

FUNDED BY
The agencies that funded the grants, contracts, or other research agreements that resulted in the patent. FedInvent includes as much information on the source of the funding as possible. The information is presented in a hierarchy going from the Federal Department down to the agencies, subagencies, and offices that funded the work. Here are two examples:

Department of Health and Human Services (HHS)
     National Institutes of Health (NIH)
         National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Department of Defense (DOD)
     Defense Advanced Research Projects Agency (DARPA)
         Army Research Office (ARO)

We do our best to provide detailed information about the funding. In some cases, the patent only reports limited information on the origins of the funding. FedInvents presents what it can confirm. We add the patents without the information required by the Bayh-Dole Act to our list of patents worthy of further investigation.

APPLICANT(S) and ASSIGNEES
FedInvent includes both the Applicants and the Assignees because having both provides more information about where the inventive work was done and by what organizations. Many organizations — universities, corporations, and federal agencies — standardize the Assignee/Owner information by the time a patent is granted. In the case of federal patents, many of the patents use the agency headquarters information for patent assignment.

Showing just the headquarters address would make Washington, DC the epicenter of all taxpayer-funded research and development. Providing both the applicant information and the assignee information provides a more accurate picture of where important taxpayer funded innovation is happening in America. Here are two examples from two different patents:

APPLICANT: U.S. Army Research Laboratory, Adelphi, MD
ASSIGNEE: The United States of America as represented by the Secretary of the Army Washington, DC

APPLICANT: Optech Ventures, LLC (Torrance, California)
ASSIGNEE(S): The Regents of the University of California (Oakland, California); Optech Ventures, LLC (Torrance, California)

INVENTOR(S)
The inventors appear in the same order as they appear on the patent. FedInvents presents the names in first name/last name order because they are easier to read than the last name/first name order of the names on the USPTO patent documents.

ABSTRACT
The abstract as it appears on the patent.

FILED
The date of the patent application including the day of the week.

APPL NO
This is the patent application serial number. If you’d like to learn more about how application serial numbers work you can go to the Lists Page.

ART UNIT
Patent data includes the Art Unit where a patent was examined. (The Art Unit isn’t available for published patent applications.) The Art Unit provides insight into what group of patent examiners prosecuted the patent application and the subject matter that the examiners work on. For example:

3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices

You can learn more about ART UNITS on the FedInvent Patents Weekly panel called About Tech Center or you can find information on the FedInvent Lists Page.

CURRENT CPC
Current CPC provides a list of the Cooperative Patent Classification symbols assigned to the patent. These are the CPC symbols assigned at the time the patent was granted.

The FedInvent Project is a patent classification maximalist endeavor or put another way, we believe that more you understand about patent classification the more you'll learn about the nature of the invention and the types of work that the federal government is funding.

The symbol presented in BOLD is the symbol identified as the "first" classification which is the most relevant classification on the patent. The date that follows the symbol is the date of the most recent revision to the art classed there.

  • A61B 1/149 (20130101)
  • A61B 1/71 (20130101)
  • A61B 1/105 (20130101)

The CPC symbols match the classifications found on the PDF version of the patent. Over time, the classifications on the full-text version of the patent change to reflect how USPTO organizes patent art to support its examiners. The two sets of CPCs don’t always match.

VIEW PATENT
As of June 2021, we include two ways to view a patent at USPTO. FedInvent provides a link to the Full-Text Version of the patent and a link to the PDF version of the patent.

HOW DO I FIND A SPECIFIC PATENT ON A PAGE?

You can use the Command F or Control F to find a specific patent you are interested in.

HOW DO I GET HERE?

You navigate to the details of a patent by clicking the information icon that follows a patent on the FedInvent Patents Weekly Report.

You can also reach this page using the weekly page link that looks like this:

https://wayfinder.digital/fedinvent/patents-2022/fedinvent-patents-20240813.html

Just update the date portion of the URL. Tuesdays for patents. Thursdays for pre-grant publication of patent applications.

Download a copy of the How To Use This Page

HAVE MORE QUESTIONS?

info@wayfinder.digital